Total Presentations: 594
1
SV Nadkarni, Trivedi, AB Jain, et al. A trauma service: First of its kind in India. Paper read at All Indian Surgeons Conference, Delhi, India. December 1975.
2
RM Kirby, JA Young, SG Hubscher, GB Cuthbertson, AB Jain, P McMaster. Cytological diagnosis of hepatic dysfunction following liver transplantation (poster). British Society of Gastroenterology, Cardiff, September 1986 (Abstract Gut 27: A1265, 1986).
3
RM Kirby, P McMaster, D Clements, SG Hubscher, L Augrisani, WAJ Jurewicz, D Adam, JAC Buckles, AB Jain, E Elias. Post-operative morbidity and mortality of liver transplantation. British
4
AB Jain, B Gunson, P McMaster. Monitoring of Cyclosporine, A in liver transplant patients. Cyclosporine A HPLC Workshop, University of Liverpool, September 1986.
5
AB Jain, P McMaster, D Adu, J Michael. Benefit of cadaveric organ transplantation using Cyclosporine A. Second International Conference on Surgery in the Tropics, Bombay, India, February 1987.
6
AB Jain, B Gunson, JAC Buckles, P McMaster. Liver transplantation: Our experience and results. . Second International Conference on Surgery in the Tropics, Bombay, India, February 1987.
7
SN Chatterji (USA), C Kurvila (USA), AB Jain (UK), Motiwala (India) Speaker and Co-Chairman. Symposium on organ transplantation. Second International Conference on Surgery in the Tropics. Bombay, India, February 1987.
8
AB Jain, B Gunson, B McDowell, JAC Buckles, E Elias, P McMaster. Pharmacokinetic studies monitoring Cyclosporine by daily trough levels in liver transplant patients. British Transplantation Society, Belfast, April 1987.
9
AB Jain, CH Young. Transperitoneal approach to upper urinary tract lesions and one-stage bilateral procedure. Midland Urology Club, West Midlands Surgical Society, November 1987.
10
AB Jain, JAC Buckles, AD Barnes, D Adu, J Michael, P Mackintosh, P McMaster. Long-term results of cyclosporine renal transplantation from a single center. The Second International Congress on Cyclosporine. Washington, DC, November 1987.
11
AB Jain, B Gunson, JAC Buckles, B McDowell, A Millis, P McMaster. Is elimination of Cyclosporine in bile dependent on liver graft functions and biliary drainage? The Second International Congress on Cyclosporine. Washington, DC, November 1987.
12
AB Jain, A Awad, D Adu, J Michael, JAC Buckles, P McMaster. Is selective conversion from Cyclosporine to Azathioprine in cadaveric renal transplant better than elective conversion? British Transplantation Society, Newcastle upon Tyne, April 1989.
13
JJ Fung, S Todo, AB Jain, J McCauley, M Alessiani, C Scotti, TE Starzl. Conversion of liver allograft recipients with Cyclosporine-related complications from Cyclosporine to FK 506. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
14
S Todo, JJ Fung, AJ Demetria, AB Jain, R Venkataramanan, TE Starzl. Early trials with FK 506 as primary treatment in liver transplantation. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
15
J McCauley, JJ Fung, AB Jain, S Todo, TE Starzl. The side effects of FK 506 upon renal function after liver transplantation. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
16
AB Jain, JJ Fung, R Venkataramanan, S Todo, M Alessiani, TE Starzl. FK 506 dosage in human organ transplantation. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
17
R Shapiro, JJ Fung, AB Jain, P Parks, S Todo, TE Starzl. The side effects of the FK 506 in humans. Symposium FK 506 IV Congress of the European Society for Organ Transplantation, Barcelona, Spain, October 31, 1989.
18
DH Van Thiel, M Iqbal, AB Jain, JJ Fung, S Todo, TE Starzl. Gastroenterology and metabolic problems associated with immunosuppression with either Cyclosporine or FK 506 in liver transplantation. Symposium FK 506 IV Congress for the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
19
L Mieles, S Todo, JJ Fung, AB Jain, H Furukawa, M Suzuki, TE Starzl. Oral glucose tolerance test in liver recipients treated with FK 506. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
20
S Stachak, S Wagner, G Block, DH Van Thiel, AB Jain, JJ Fung, S Todo TE Starzl. A cost comparison of liver transplantation with FK 506 or Cyclosporine as the primary immunosuppressive agent. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
21
R Venkataramanan, AB Jain, E Cadoff, VS Warty, A Krajack, O Imventarza, S Todo, JJ Fung, TE Starzl. Pharmacokinetics of FK 506 pre-clinical and clinical studies. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
22
AB Jain, R Venkataramanan, E Cadoff, JJ Fung, S Todo, A Krajack, TE Starzl. Effect of hepatic dysfunction and T-tube clamping of FK 506 pharmacokinetics and trough concentrations. Symposium FK 506 IV Congress of the European Society for Organ Transplantation. Barcelona, Spain, October 31, 1989.
23
AB Jain, GJ Burckart, W Diven, R Venkataramanan, TE Starzl. Cyclosporine measurement by FPIA, PcRIA, and HPLC following liver transplantation. Cyclosporine Therapeutic Drug Monitoring. Hawks Bay, Florida, January 1990. of Cyclosporine: Clinical correlation with drug monitoring. Cyclosporine Therapeutic Drug Monitoring. Hawks Bay, Florida, January 1990.
25
JJ Fung, S Todo, AJ Demetris, AB Jain, M Alessiani, A Tzakis, TE Starzl. Use of FK 506 in the treatment of chronic liver allograft rejection. American Society of Surgical Transplantation. Chicago, IL, 1990.
26
R. Venkataramanan, AB Jain, VS Warty, K Abu-Elmagd, H Furukawa, O Imventarza, JJ Fung, S Todo, TE Starzl. Pharmacokinetics of FK 506 following oral administration. A comparison of FK 506 and Cyclosporine. XIII International Congress of the Transplantation Society, San Francisco, August 1990.
27
JJ Fung, S Todo, A Tzakis, AJ Demetris, AB Jain, K Abu-Elmagd, M Alessiani, TE Starzl. Conversion of liver allograft recipients from Cyclosporine to FK 506-based immunosuppression: Benefits and pitfalls. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.
28
S. Todo, JJ Fung, A Tzakis, AJ Demetris, AB Jain, M Alessiani, S Takaya, TE Starzl. 110 consecutive primary orthotopic liver transplantation under FK 506 in adults. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.
29
M. Alessiani, S Kusne, M Martin, AB Jain, K Abu-Elmagd, J Moser, JJ Fung, TE Starzl. Infection in adult liver transplant patients under FK 506 immunosuppression. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.
30
J McCauley, S Takaya, JJ Fung, A Tzakis, K Abu-Elmagd, AB Jain, S Todo, TE Starzl. The question of FK 506 nephrotoxicity. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.
31
S Kusne, M Martin, R Shapiro, M Jordan, M Alessiani, AB Jain, S Todo, TE Starzl. Early infections in kidney transplant recipients under FK 506. XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.
32
A Zeevi, G Eiras, C Kaufman, M Alessiani, AJ Demetris, K Abu-Elmagd, AB Jain, V Warty, R Venkataramanan, G Burckart, TE Starzl, S Todo, JJ Fung, R Duquesnoy, XIII International Congress of the Transplantation Society, San Francisco, CA, August 1990.
33
JJ Fung, S Todo, A Tzakis, M Alessiani, K Abu-Elmagd, AB Jain, O Bronsther, M Martin, R Gordon, TE Starzl. Current status on FK 506 in liver transplantation. First Symposium of the International
34
M Alessiani, AB Jain, K Abu-Elmagd, S Todo, JJ Fung, TE Starzl. An overview on clinical organ transplantation under FK 506. Proceedings of the 22nd International Course of Transplantation and Clinic Immunology, Lyon, France, May 1990.
35
AB Jain, JJ Fung, S Todo, K Abu-Elmagd, M Alessiani, S Takaya, A Tzakis, TE Starzl. Preliminary results of prospective randomized trial of FK 506 versus Cyclosporine (CyA) in orthotopic liver transplantation. British Transplantation Society, Cambridge, April 1991.
36
M. Alessiani, C Ricordi, JJ Fung, K Abu-Elmagd, Jain AB, C. Scotti, A Pinna, U Cillo, G Carrieri, TE Starzl. USO Clinico Del. FK 506 NEL Trapianto di Fegato 1991.
37
AB Jain, R Venkataramanan, S Todo, JJ Fung, K Abu-Elmagd, M Alessiana, TE Starzl. Intravenous, oral pharmacokinetics and dosing of FK 506 in small bowel transplant patients. Second International Symposium on Small Bowel Transplantation. Toronto, Ontario, Canada, October 1991.
38
J Reyes, K Abu-Elmagd, B Nour, S Kusne, M Green, M Alessiani, AB Jain, JJ Fung, A Tzakis, S Todo, TE Starzl. Infectious complications after human small bowel transplantation. Second International Symposium on Small Bowel Transplantation, Toronto, Ontario, Canada, October 1991.
39
AB Jain, S Todo, JJ Fung, R Day, J Bryant, D Abu-Elmagd, M Alessiani, S Takaya, A Tzakis, VS Warty, R Venkataramanan, TE Starzl. Correlation of episodes of rejections with FK dosage and FK level following primary orthotopic liver transplantation. First International Congress on FK 506.
40
AB Jain, JJ Fung, A Tzakis, K Abu-Elmagd, S Mehta, M Alessiani, S Todo, J Reyes, VS Warty, R Venkataramanan, TE Starzl. Comparative study of Cyclosporine and FK 506 dosage requirement in PA, August 1991.
41
AB Jain, R Venkataramanan, JJ Fung, W Diven, VS Warty, K Abu-Elmagd, S Todo, M Alessiani, TE Starzl. Pharmacokinetics of Cyclosporine and nephrotoxicity in orthotopic liver transplant patients
42
S Wagner, J Depee, I Felser, AB Jain, JJ Fung, TE Starzl, S Stanczak. Changes in quality-of-life following conversion from CyA to FK 506 in orthotopic liver transplant patients. First International
43
S Takaya, O Bronsther, S Todo, K Abu-Elmagd, AB Jain, M Alessiani, JJ Fung, R Gordon, TE Starzl. Re-transplantation of the liver: A comparison of FK 506 Cyclosporine-treated patients. First
44
M Alessiani, S Kusne, J Torre-Cisneros, M Martin, AB Jain, K Abu-Elmagd, S Takaya, U Cillo, S Todo, et al. The incidence of CMV infection during a randomized trial comparing cyclosporine to FK August 1991.
45
S Kusne, JJ Fung, M Alessiani, K Abu-Elmagd, AB Jain, S Takaya, J Torre-Cisneros, et al. The incidence of infections during a randomized trial comparing Cyclosporine to FK 506 August 1991.
46
K Abu-Elmagd, O Bronsther, Y Iwaki, M Kobayashi, A Yagihashi, F Bontempo, JJ Fung, M Alessiani, AB Jain, A Tzakis, S Todo, DH Van Thiele, TE Starzl. Acute hemolytic anemia in liver and bone PA, August 1991.
47
JJ Fung, R Gordon, S Todo, A Tzakis, AB Jain, K Abu-Elmagd, S Takaya, M Alessiani, R Selby, AJ Demetris, et al. The use of FK 506 in primary liver transplantation. First International Congress on FK
48
K Abu-Elmagd, JJ Fung, M Alessiani, AB Jain, S Takaya, R Venkataramanan, VS Warty, et al. The strategy of FK 506 therapy in liver transplant patients: The effect of graft function. First International Alessiani, S Takaya, R Venkataramanan, VS Warty, W Shannon, A Tzakis, S Todo, TE Starzl. Four- hour versus 24-hour intravenous infusion of FK 506 in primary liver recipients. First International
49
TL Whiteside, J Wilson, A Zeevi, K Abu-Elmagd, AB Jain, JJ Fung, R Herberman, TE Starzl. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients August 1991.
50
R Shapiro, M Jordan, V Scantlebury, JJ Fung, C Jensen, A Tzakis, P Carroll, J McCauley, C Ricardi, S Mitchell, RS Day, AB Jain, Y Iwaki, J Reyes, S Todo, et al. FK 506 in clinical kidney transplantation.
51
S Takaya, O Bronsther, S Todo, K Abu-Elmagd, AB Jain, M Alessiani, JJ Fung, RD Gordon, TE Starzl. Re-transplantation of the liver: A comparison of FK 506 and Cyclosporine-treated patients. First
52
J McCauley, R Shapiro, A Tzakis, AB Jain, N Gilboa, M Jordan, C Jensen, D Ellis, TE Starzl. Renal transplantation under FK 506 in patients with previous renal failure due to hemolytic uremic syndrome
53
R Venkataramanan, AB Jain, Abu-Elmagd, H Abdallah, VS Warty, S Todo, JJ Fung, TE Starzl. Pharmacokinetics of FK 506 in liver transplant patients. First International Congress on FK 506.
54
A Zeevi, G Eiras, V Warty, R Venkataramanan, K Abu-Elmagd, M Alessiani, AB Jain, AJ Demetris, S 1991.
55
J McCauley, JJ Fung, S Todo, AB Jain, TE Starzl. Renal function in liver transplant patients under FK
56
B Eidelman, K Abu-Elmagd, J Wilson, M Alessiani, AB Jain, S Takaya, S Todo, A Tzakis, DH Van Thiel, TE Starzl. Neurotoxicity of FK 506 in liver and thoracic organ transplant recipients. First
57
JJ Fung, K Abu-Elmagd, A Tzakis, M Alessiani, E Bloom, AB Jain, D Przepiorka, J Reyes, C Rosenfield, AJ Demetris, R Gordon, TE Starzl. Treatment of chronic graft-versus-host disease (GVHD) PA, August 1991.
58
M Roat, JJ Fung, AB Jain, TE Starzl, R Thoft. FK 506 for the treatment of scleritis, uveitis, keratitis, and hearing loss. A case report of Cogan’s syndrome. First International Congress on FK 506.
59
B Jegasothy, K Abu-Elmagd, C Ackerman, M Alessiani, AB Jain, A Thomson, S Wagner, JJ Fung, S Todo, DH Van Thiel, TE Starzl. Efficacy of FK 506 in the treatment of pyoderma gangrenosum. First
60
AB Jain, K Abu-Elmagd, M Alessiani, JJ Fung, S Todo, S Takaya, R Gordon, A Tzakis, TE Starzl. Side effects of FK 506 compared to Cyclosporine in a prospective randomized trial of orthotopic liver
61
J McCauley, JJ Fung AB Jain, S Todo, TE Starzl. Renal function after conversion from Cyclosporine to 1991.
62
AJ Demetris, JJ Fung, S Todo, AB Jain, S Takaya, M Alessiani, K Abu-Elmagd, DH Van Thiel, TE Starzl. Conversion of liver allograft recipients from Cyclosporine to KF 506 immunosuppressive
63
M Alessiani, JJ Fung, K Abu-Elmagd, AB Jain, S Takaya, A Tzakis, S Todo, TE Starzl. A prospective randomized trial comparing Cyclosporine versus FK 506 in primary liver transplantation. Proceedings of the 5th International Congress of the European Society of Organ Transplantation. Maastricht, Netherlands, October 6-10, 1991.
64
M Alessiani, C Ricordi, JJ Fung, K Abu-Elmagd, AB Jain, C Scotti, A Pinna, U Cillo, G Carrieri, G Zetti, TE Starzl. USO Clinico Del—FK 506 Nel Trapianto Di Fegato. In All Trapianto Oggi—Proceedings of the 21st Congress of the Italian Society of Organ Transplantation. Ed. Monduzzi: 611-615, 1991.
65
J McCauley, Y Onodera, H Woods, W Irish, JJ Fung, AB Jain, S Todo, TE Starzl. The renal consequences of orthotopic liver transplant rescue therapy with FK 506: three year’s follow up. American Society of Transplant Physicians 11th Annual Scientific Meeting, 1992.
66
AB Jain, N Jabbour, H Ramos, JJ Fung, TE Starzl, DH Van Thiel. Incidence and severity of liver allograft rejection following institution of Alpha Interferon for treatment of viral hepatitis in liver transplant recipients. 94th Annual Meeting of the American Gastroenterological Association, May 1993, Boston, MA, (Abstract) Gastroenterology 104(4)2, A922, 1993.
67
AB Jain, R Venkataramanan, JJ Fung, VS Warty, A Tzakis, S Todo, TE Starzl. Pregnancy in liver transplant patients under FK 506 regimen. 12th American Society of Transplant Physicians. Houston, TX, May 1993.
68
AB Jain, JJ Fung, S Todo, A Tzakis, R Selby, H Ramos, K Abu-Elmagd, J McCauley, R Venkataramanan, TE Starzl. Three-year follow-up of adults receiving primary orthotopic liver transplantation under FK 506. Second Congress of the International Liver Transplantation Society. Toronto, Canada, October 1993.
69
JJ Fung, AB Jain, I Hamad, H Doyle, R Selby, A Tzakis, S Todo, TE Starzl. Long-term effects of FK 506 following conversion from Cyclosporine to FK 506 for chronic rejection in liver transplant recipients. 44th American Association for the Study of Liver Disease. Chicago, IL, November 1993. Abstract: Hepatology 18(4):2, 74A, 1993.
70
AB Jain, R Venkataramanan, J Lever, VS Warty, K Abu-Elmagd, H Furukawa, J Reyes, B Nour, A Arthur, A Tzakis, S Todo, TE Starzl. FK 506 in small bowel transplant recipients: Pharmacokinetics and dosing aspects. Third International Symposium on Small Bowel Transplantation. Paris, France, November 1993.
71
AB Jain, A Tasamandas, AJ Demetris, W Irish, H Ramos, N Jabbour, L Echeverri, DH Van Thiel, TE Starzl, JJ Fung. Interferon Alpha 2B for Non-A, Non-B, and Non-C hepatitis in liver allograft recipients. Clinical and Pathological Outcome. 45th American Association for the Study of Liver Diseases. Chicago, IL, November 11-15, 1994. Abstract: Hepatology 20(4):2, 13A, October 1994.
72
AB Jain, JJ Fung, S Todo, H Ramos, R Selby, W Irish, J Reyes, N Jabbour, R Venkataramanan, TE Starzl. Adult primary orthotopic liver transplantation under FK 506: four-year follow up. 45th American Association for the Study of Liver Diseases. Chicago, IL, November 11-15, 1994. Abstract: Hepatology 20(4):2, 137A, October 1994.
73
AB Jain, A Tasamandas, AJ Demetris, W Irish, R Manez, H Ramos, N Jabbour, L Echeverri, DH Van Thiel, TE Starzl, JJ Fung. Clinical outcome and pathological correlation following Interferon Alpha 2B treatment of recurrent hepatitis B and hepatitis C in orthotopic liver allograft recipients. 45th American Association for the Study of Liver Diseases. Chicago, IL, November 11-15, 1994. Abstract: Hepatology 20(4):2, 130A, October 1994.
74
R Venkataramanan, AB Jain, J Lever, VS Warty, S Mehta, G Burckart, R Shapiro, M Jordan, J Reyes, B Nour, JJ Fung, S Todo, TE Starzl. High dose FK506 requirement in transplant patients. 15th World Congress of the Transplantation Society. Kyoto, Japan, August 28 – September 2, 1994.
75
AB Jain, JJ Fung, S Todo, R Selby, H Ramos, T Gayowski, K Abu-Elmagd, O Bronsther, N Jabbour, A Tzakis, TE Starzl. Conversion from FK 506 to Cyclosporine due to FK 506 toxicity following orthotopic liver transplantation. American Society of Transplant Physicians 13th Annual Scientific Meeting, Chicago, IL, May 16-18, 1994.
76
Bronsther, R Manez, S Kusne, W Irish, W Roland, AB Jain, R Lull, AJ Demetris, TE Starzl. Recurrent or de novo B and C hepatitis influence the development of vanishing bile duct syndrome after liver transplantation. 15th World Congress of the Transplantation Society, Kyoto, Japan, August 28 - September 2, 1994.
77
B Nour, J Reyes, A Tzakis, S Todo, M Green, AB Jain, JJ Fung, TE Starzl. Pediatric primary liver transplantation under FK 506 immunosuppression: Four-year experience. 15th World Congress of the Transplantation Society. Kyoto, Japan, August 28 – September 2, 1994.
78
AB Jain, JJ Fung, S Todo, R Selby, W Irish, A Tzakis, K Abu-Elmagd, J Reyes, B Nour, J McMichael, S Mitchell, O Bronsther, et al. One thousand consecutive primary liver transplantations under FK 506: Survival and adverse events. 15th World Congress of the Transplantation Society. Kyoto, Japan, August 28 - September 2, 1994.
79
J McCauley, Y Onodera, H Woods, W Irish, JJ Fung, AB Jain, S Todo, TE Starzl. The renal consequences of orthotopic liver transplant resume therapy with FK 506: Three-year follow up. American Society of Transplant Physicians 13th Annual Scientific Meeting. Chicago, IL, May 16-18, 1994.
80
AB Jain, A Tasamandas, N Jabbour, JJ Fung, J Rakela, TE Starzl, AJ Demetris. Long-term clinical and histopathological impact of Alpha Interferon 2B treatment in liver allograft recipients for recurrent hepatitis C viral Disease. American Association for the Study of Liver Diseases: Liver transplantation for chronic viral hepatitis. Reston, VA, March 1995.
81
AB Jain, JJ Fung, S Todo, R Selby, A Casavilla, N Jabbour, H Doyle, D Kramer, Y Kang, W Irish, S Kusne, TE Starzl. Morbidity other than rejection with primary liver transplantation: 1,000 consecutive cases. American Society of Transplant Physician’s 14th Annual Scientific Meeting. Chicago, IL, May 14-17, 1995.
82
J Reyes, AB Jain, S Todo, M Green, JJ Fung, N Jabbour, TE Starzl. Pediatric primary orthotopic liver transplantation under tacrolimus. First International Liver Transplantation Society and Liver Intensive and Surgery 1(6): 425, November 1995.
83
J Reyes, AB Jain, S Todo, JJ Fung, M Green, N Jabbour, TE Starzl. Conversion from Cyclosporine to tacrolimus in pediatric liver transplant recipients. First International Liver Transplantation Society and Transplantation and Surgery 1(6):425, November 1995.
84
AB Jain, JJ Fung, I Hamad, S Todo, J Reyes, D Kramer, A Casavilla, J Rakela, AJ Demetris, TE Starzl. Long-term outcome of conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: Actual more than five-year follow-up. First International Liver Transplantation Society and Liver Transplantation and Surgery 1(6):425, November 1995.
85
AB Jain, JJ Fung, I Hamad, S Todo, J Reyes, N Jabbour, D Kramer, A Casavilla, J Rakela, JW Marsh, S Iwatsuki, TE Starzl. Adult primary liver transplantation under tacrolimus: More than five- years’ actual follow up. First International Liver Transplantation Society and Liver Intensive Care Group Europe. 1(6):425, November 1995
86
AF Dimartini, AB Jain, JJ Fung, W Irish, J Magill, J Rakela, TE Starzl. Liver transplantation in alcoholic and non-alcoholic cirrhosis: Survival according to UNOS status, sobriety and rehabilitation. The International Liver Transplantation Society and Liver Intensive Care Group Europe. London, November 1995.
87
N Jabbour, AB Zajko, J Reyes, AB Jain, W Irish, J Rakela, JJ Fung. Does trans-jugular intrahepatic portosystemic shunt (TIPS) correct thrombocytopenia associated with liver cirrhosis? The International Liver Transplantation Society and Liver Intensive Care Group Europe. September 27- 30, 1995. 1(6):425, November 1995.
88
AB Jain, R Venkataramanan, JJ Fung, J Reyes, J Lever, VS Warty, S Todo, TE Starzl. Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pediatric and adult liver transplant recipients. The American Association for the Study of Liver Diseases. Chicago, IL, November 3-7, 1995. Abstract: Hepatology 22(4):2: 143A, October 1995.
89
R Venkataramanan, AB Jain, J Lever, VS Warty, S Mehta, G Burckart, R Shapiro, M Jordan, J Reyes, B Nour, JJ Fung, S Todo, TE Starzl. Pharmacokinetics of tacrolimus in transplant patients. Proceedings of the 4th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, 1995.
90
VS Warty, S Zuckerman, T McAvaneys, S Mehta, K Velmar, J Chao, AB Jain, R Venkataramanan. Comparison between whole-blood tacrolimus by Abbott, Inc. and plasma tacrolimus by enzyme-linked immunoassay. Proceedings of the 4th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, 1995.
92
J Tabasco-Minguillan, AB Jain, M Naik, K Weber, JJ Fung, W Irish, J Rakela, TE Starzl. Incidence and causes of gastrointestinal bleeding in adults following liver transplantation. 96th Annual Meeting of the American Gastroenterological Association. San Francisco, CA, May 19-22, 1996.
93
AB Jain, R Venkataramanan, J Lever, S Zuckerman, VS Warty, I Hamad, JJ Fung, TE Starzl. Pharmacokinetics of Mycophenolate Mofetil and its potential interaction with tacrolimus. American Society of Transplant Surgeons 22nd Annual Scientific Meeting. Dallas, TX, May 29-31, 1996.
94
AB Jain, L Yee, M Nalesnik, JJ Fung, J Reyes, J Rakela, TE Starzl. De novo non-lymphoid malignancies, following 1000 consecutive liver transplantation under tacrolimus. American Society of Transplant Physicians 15th Annual Meeting. Dallas, TX, May 26-30, 1996.
95
PA Kelly, RF Frye, GJ Burckart, R Venkataramanan, AB Jain, JJ Fung, M Romkes, RA Branch. Tacrolimus dosing in stable liver transplant (OLTx) recipients correlates with phenotypic CYP34A enzyme activity but not leukocyte CYP3A4 in RNA expression. American Society of Transplant Physicians 15th Annual Meeting. Dallas, TX, May 26-30, 1996.
96
AK Singhal, AB Jain, J Martell, JJ Fung, W Irish, S Todo, J Reyes, TE Starzl. Impact of positive cross match due to IgG versus IgM antibodies on the outcome of primary liver transplantation under tacrolimus. American Society of Transplant Physicians 15th Annual Meeting. Dallas, TX, May 26-30, 1996.
97
AB Jain, J Reyes, L Mieles, JJ Fung, S Todo, J McMichaels, TE Starzl. Conversion of pediatric liver allograft recipients from Cyclosporine to tacrolimus-based immunosuppression. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10 C31-C94, 1996.
98
A Khanna, AB Jain, G Ziady, JJ Fung, R Jaffe, L Mieles, TE Starzl, J Reyes. Cardiac changes at autopsy in pediatric liver transplant recipients under tacrolimus. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.
99
J Reyes, J Fricker, L Mieles, E Jovine, AB Jain, S Todo, JJ Fung, H Noyola, TE Starzl. Reversible myocardial hypertrophy after liver and liver-small bowel transplantation in children under Tacrolimus (FK 506) immunosuppression. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.
100
AB Jain, L Mieles, S Todo, JJ Fung, J McMichael, TE Starzl, J Reyes. Primary liver transplantation in children under tacrolimus. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.
101
A Khanna, AB Jain, L Mieles, JJ Fung, S Todo, TE Starzl, J Reyes. Liver re-transplantation in children: Study of 184 cases. The 2nd International Congress on Pediatric Transplantation. Paris, France, August 22-24, 1996. Abstract: Pediatric Nephrology 10:C31-C94, 1996.
102
A Khanna, AB Jain, G Ziady, JJ Fung, AJ Demetris, TE Starzl, D Kramer. Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. XVI International Congress of the Transplantation Society. Barcelona, Spain, August 25-30, 1996.
103
P Kelly, R Frye, GJ Burckart, R Venkataramanan, AB Jain, JJ Fung, M Romkes, RA Branch. Tacrolimus dosing in stable liver transplant (OLTx) recipients correlates with phenotypic CYP3A4 enzyme activity but not leukocyte CYP3A4 mRN expression. American College of Clinical Pharmacy Annual Meeting, 1996.
104
AB Jain, JJ Fung, S Todo, J Reyes, D Kramer, A Casavilla, J Rakela, S Iwatsuki, TE Starzl. More than six years’ actual follow up: Primary adult liver transplantation under tacrolimus. The 47th American Association for the Study of Liver Disease 1996. Abstract: Hepatology 24(4):181A.
105
AB Jain, JJ Fung, S Todo, J Rakela, AJ Demetris, S Iwatsuki, TE Starzl. More than six years’ actual follow up conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection. The 47th American Association for the Study of Liver Disease 1996. Abstract: Hepatology 24(4):181A.
106
AB Jain, M Gadomski, JJ Fung. Conversion from Cyclosporine to Neoral in stable liver transplant recipients. The 47th American Association for the Study of Liver Disease 1996. Abstract: Hepatology 24(4):181A.
107
AB Jain, JJ Fung, I Hamad, J Rakela, J Demetris, J McMichael, TE Starzl. Prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil in primary adult liver transplant recipients. Oral presentation at the Joint American Society of Transplant Physicians 16th and Surgeons 23rd. Chicago, IL, May 1997.
108
AB Jain, A Tasamandas, J Rakela, A Demetris, TE Starzl, JJ Fung. Long-term effect of Interferon Alpha for HCV infection post-liver transplantation: Actual five-to-seven-years’ follow up. American Association for the Study of Liver Disease. Virginia, June 1997.
109
E Molmenti, J Bueno, R Venkataramanan, AB Jain, S Todo, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after liver and intestinal transplantation. 16th American Society of Transplant Physicians. Chicago, IL, May 10-14, 1997.
110
E Molmenti, J Bueno, K Abu-Elmagd, R Venkataramanan, AB Jain, S Todo, JJ Fung, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after intestinal transplantation. Fifth 2, 1997.
111
E Molmenti, J Bueno, R Venkataramanan, JJ Fung, AB Jain, S Todo, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after liver and intestinal transplantation. Fourth Congress of the International Liver Transplantation Society. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5): C-78(189), 1997.
112
E Molmenti, J Bueno, T Cacciarelli, B Kosmach, AB Jain, JJ Fung, J Reyes. Adolescent noncompliance following liver transplantation. Fourth Congress of the Liver Transplantation Society. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5): C-77 (188), 1997.
113
AB Jain, JJ Fung, I Hamad, J Rakela, J Demetris, J McMichael. Prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone, and Mycophenolate Mofetil in primary adult liver transplant recipients. Fourth Congress of the Liver Transplantation Society’s Plenary Session. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5): C-55(70), 1997.
114
AB Jain, JJ Fung, S Todo, J Reyes, D Kramer, J Rakela, TE Starzl. More than seven years’ actual follow-up: Primary adult liver transplantation under tacrolimus. Fourth Congress of the International Liver Transplantation Society. Seattle, WA, October 15-17, 1997. Abstract: Liver Transplantation and Surgery 3(5): C-71(162), 1997.
115
AB Jain, A Singhal, JJ Fung, R Lee, AC Tasamandas, TE Starzl, J Demetris. Chronic rejection following primary adult liver transplantation under tacrolimus. 48th American Association for the Study of Liver Diseases. Chicago, IL, November 7-11, 1997. Abstract: Hepatology 29(4):2; 343-A, 1997. Abstract #859.
116
AB Jain, R Kashyap, B Carr, J Rakela, JJ Fung. Clinical significance of elevated serum alpha- fetoprotein among patients with end-stage liver disease. 48th American Association for the Study of Liver Diseases. Chicago, IL, November 7-11, 1997. Abstract: Hepatology 29(4):2; 171A, 1997. Abstract #171.
117
AB Jain, JJ Fung, I Hamad, S Zuckerman. Use of Mycophenolate Mofetil for tacrolimus-related chronic nephrotoxicity in liver transplantation recipients. 48th American Association for the Study of Liver Diseases. Chicago, IL, November 7-11, 1997. Abstract: Hepatology 29(4)2; 235A, 1997. Abstract #429.
118
AB Jain, J Reyes, R Kashyap, M Nalesnik, T Cacciarelli, J McMichael, S Rohal, T Starzl, JJ Fung. Long-term use of tacrolimus in liver transplant recipients. The First International Congress on Immunosuppression. Orlando, FL, December 10-13, 1997.
119
AB Jain, I Hamad, JJ Fung. Conversion from tacrolimus to Neoral in adult liver transplant patients. The First International Congress on Immunosuppression. Orlando, FL, December 10-13, 1997.
120
AB Jain, JJ Fung, I Hamad, J Demetris, F Dodson, TE Starzl. Adult primary liver transplantation: Prospective randomized trial of tacrolimus and Mycophenolate Mofetil. The First International Congress on Immunosuppression. Orlando, December 10-13, 1997.
121
AB Jain, I Hamad, D Brody, JJ Fung. Use of Neoral for neurological complications following primary adult liver transplantation under tacrolimus. New Dimensions in Transplantation. Florence, Italy, February 16-19, 1998.
122
AB Jain, Mary Gadomski, JJ Fung. A prospective study on conversion from Cyclosporine to Neoral in stable adult liver transplant recipients. New Dimensions in Transplantation. Florence, Italy, February 16-19, 1998.
123
AB Jain, JJ Fung, I Hamad, F Dodson, J Rakela, D Kramer, J McMichael, TE Starzl. Adult primary liver transplantation: Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid, and Mycophenolate Mofetil. American Society of Transplant Surgeons 24th Annual Meeting. Chicago, IL, May 13-15, 1998. Abstract: Transplantation 66(6): S2, 1998.
124
AB Jain, JJ Fung, J Reyes, R Kashyap, S Rohal, J Rakela, T Cacciarelli, TE Starzl. Primary liver transplantation under tacrolimus in infants, children, adults, and seniors: 1000 consecutive patients from a single center with five-to-eight years’ actual follow-up. American Society of Transplant Surgeons 24th Annual Meeting. Chicago, IL, May 13-15, 1998. Abstract: Transplantation 66(6): S43 (172), 1998.
125
AB Jain, J McCauley, R Kashyap, J Reyes, R Shapiro, JJ Fung. Incidence of end-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: adults and children. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.
126
I Hamad, AB Jain, JJ Fung, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia in peripheral blood leukocytes and pre-emptive therapy. American Society of Transplant Surgeons’ 19th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.
127
J Reyes, AB Jain, G Mazarietos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporine to tacrolimus-based immunosuppression: Four-to-eight years’ follow up. American Society of Transplant Physicians’ 17th Annual Scientific meeting, Chicago, IL, May 9-13, 1998.
128
J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, T Starzl, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow up. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.
129
E Molmenti, J Bueno, T Cacciarelli, J DeBlassi, B Kosmach, AB Jain, JJ Fung, G Mazariegos, J Reyes. Noncompliance after pediatric liver transplantation. American Society of Transplantation Physician’s 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.
130
E Molmenti, AB Jain, R Shapiro, F Dodson, E Totsuka, JJ Fung. Kidney transplantation for end- stage renal failure in liver transplant recipients with hepatitis C viral infection. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.
131
J McCauley, F Dodson, AB Jain, J Rakela, S Rohal, P Randhawa, JJ Fung. Hepatitis C-related glomerulonephritis: A growing cause of renal failure after liver transplantation. American Society of Transplant Physicians’ 17th Annual Scientific Meeting, Chicago, IL, May 9-13, 1998.
132
J Reyes, AB Jain, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporine to tacrolimus-based immunosuppression: Four-to-eight years’ follow-up. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
133
J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, TE Starzl, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow-up. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
134
I Dvorchik, TV Cacciarelli, AB Jain, G. Mazariegos, JJ Fung, J Reyes. Indications and results of hepatic retransplantation in children receiving primary tacrolimus therapy. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
135
TV Cacciarelli, I. Dvorchik, AB Jain, D Gerber, G. Mazariegos, JJ Fung, J Reyes. Pre-transplant risk factors and long-term liver allograft outcomes in children receiving primary tacrolimus therapy. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
136
J Bueno, E Molmenti, J Bueno, TV Cacciarelli, J DeBlassi, B Kosmach, AB Jain, JJ Fung, G Mazariegos, J Reyes. Noncompliance after pediatric liver transplantation. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
137
AB Jain, JJ Fung, J Reyes, R Kashyap, S Rohal, J Rakela, TE Starzl. Primary liver transplantation under tacrolimus in infants, children, adults, and seniors: 1000 consecutive patients from a single center with five-to-eight years’ actual follow-up. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
138
AB Jain, JJ Fung, I Hamad, F Dodson, J Rakela, D Kramer, J McMichael, TE Starzl. Adult primary liver transplantation: Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid, and Mycophenolate Mofetil. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
139
E Molmenti, AB Jain, R Shapiro, F Dodson, E Totsuka, JJ Fung. Kidney transplantation for end- stage renal failure in liver transplantation recipients’ carriers of hepatitis C virus. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
140
V Donnenberg, D Griffin, G Burckhardt, AB Jain, A Donnenberg. P-Glycoprotein (p-gp) is responsible for drug elimination in peripheral T-cells from solid organ and stem cell transplantation recipients. The 1998 Transplantation Society’s XVII World Congress. Montreal, Canada, July 12-17, 1998.
141
E Molmenti, J Bueno, R Venkataramanan, JJ Fung, AB Jain, S Todo, J Reyes. Use of Mycophenolate Mofetil in the pediatric population after liver and intestinal transplantation. Third International Congress on Pediatric Transplantation, 1998. Abstract: Ped Transplantation 174(2) 1998. Abstract # 175.
142
AB Jain. Liver transplantation today. First International Workshop (Neurological Problems and Liver Transplantation). Bologna, Italy, May 8, 1998.
143
J Reyes, AB Jain, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporine and tacrolimus-based immunosuppression: Four-to-eight years’ follow-up. The International Congress on Pediatric Transplantation, 1998. Abstract: Ped Transplantation 75(2), 1998. Abstract #177.
144
E Molmenti, J Bueno, T Cacciarelli, B Kosmach, J DE Blass, AB Jain, JJ Fung, G Mazariegos, J Reyes. Noncompliance after pediatric liver transplantation: 2(1); 78, 1998. Abstract: Ped Transplantation 78(2), 1998. Abstract #192.
145
J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, TE Starzl, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow-up. Third International Congress on Pediatric Transplantation. Abstract: Ped Transplantation 2(1); 75, 1998.
146
T Cacciarelli, G Mazariegos, I Dvorchik, AB Jain, JJ Fung, J Reyes. Indications and results of hepatic retransplantation in children receiving primary tacrolimus therapy. Third International Congress on Pediatric Transplantation: Ped Transplantation 183(2), 1998. Abstract #181.
147
J Barnes, AB Jain, L Ondick, C Hartner, R Kashyap, B Carr, JJ Fung. Clinical significance of elevated serum alpha-fetoprotein among patients with end-stage liver disease. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.
148
N Marino, AB Jain, B Flynn, L Kingery, K Nestler, C Hartner, V Raman, J Lever, JJ Fung. Prospective study of pregnancy following liver transplantation under tacrolimus. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR, September 10-12, 1998.
149
M Gadomski, AB Jain, L Kingery, K Nestler, C Hartner, JJ Fung. Conversion from Cyclosporine to Neoral in stable adult liver transplant recipients. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
150
S Rohal, AB Jain, K Iuliano, C Gronsky, C Hartner, J Reyes, R Kashyap, JJ Fung. Primary liver transplantation under tacrolimus in infants, children, adults, and seniors: 1000 consecutive cases; mean follow-up 76 months. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
151
K Nestler, AB Jain, I Hamad, C Hartner, JJ Fung. Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid, and Mycophenolate Mofetil in primary liver transplant. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
152
C Gronsky, AB Jain, K Iurlano, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus-based immunosuppression: Four-to-eight years’ follow up. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
153
K Iurlano, AB Jain, C Gronsky, G Mazariegos, R Kashyap, C Hartner, JJ Fung. Primary liver transplantation in children under tacrolimus: Three-to-eight years’ actual follow-up. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
154
M Zak, AB Jain, B Yelochan, L Kingery, K Nestler, C Hartner, A Youk, JJ Fung. Comparative incidence of de novo non-lymphoid malignancies following liver transplantation under tacrolimus using surveillance epidemiologic end-result data. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
155
M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
156
D Brody, AB Jain, L Kingery, K Nestler, C Hartner, JJ Fung. Use of neural for post-liver transplant neurological complications under tacrolimus. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
157
A Rafail, AB Jain, L Kingery, K Nestler, C Hartner, J McCauley, R Kashyap, JJ Fung. Incidence of end-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: adults and children. The Seventh Annual International Transplant Nurses Society Symposium and General Assembly. Portland, OR September 10-12, 1998.
158
AB Jain, I Hamad, R Kashyap, SN Rishi, D Kramer, J Rakela, JJ Fung. Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid versus tacrolimus, steroid and Mycophenolate Mofetil in primary adult liver transplantation. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4)2; 221A, 1998. Abstract #233.
159
AB Jain, AK Singhal, J Reyes, J Rakela, JJ Fung. Long-term impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus. 49th American Association for the Study of Liver disease and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4); 2, 351A, 1998. Abstract #756.
160
AB Jain, J Reyes, R Kashyap, N Rishi, S Rohal, J Rakela, JJ Fung. Primary liver transplant under tacrolimus in infants, children, adults, and seniors: 1000 consecutive cases: mean follow-up seven years. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4); 2, 351A, 1998. Abstract #755.
161
J Reyes, AB Jain, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus-based immunosuppression: Mean seven years’ actual follow up. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4); 2, 351A, 1998. Abstract #754.
162
J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, N Rishi, JJ Fung. Primary liver transplantation in children under tacrolimus and Cyclosporine: Comparative study. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4); 2, 351A, 1998. Abstract #753.
163
AB Jain, J Demetris, J Rakela, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than eight years’ actual follow-up. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4);2, 221A, 1998. Abstract #233.
164
R Venkataramanan, J Ou, S Zuckerman, J Pisupati, AB Jain. A plasma protein binding of Mycophenolic acid affects its clearance. 49th American Association for the Study of Liver Diseases and International Association for the Study of the Liver. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4); 2, 271A, 1998. Abstract #434.
165
AB Jain, A DiMartini, N Rishi, MG Fitzgerald, S Rohal, J Rakela, JJ Fung. Long-term results of liver transplantation for alcoholic-related liver disease under tacrolimus. 49th American Association for the Study of Liver Diseases and International Association for the Study of Liver Diseases. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4) 2:350A, 1998. Abstract: #752.
166
AB Jain, I Hamad, R Kashyap, N Rishi, D Kramer, J Rakela, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary adult liver transplantation. 49th American Association for the Study of Liver Diseases and International Association for the Study of Liver Diseases. Chicago, IL, November 4-10, 1998. Abstract: Hepatology 28(4) 2:241A, 1998. Abstract: #313.
167
AB Jain, J Reyes, S Rohal, TE Starzl, JJ Fung. 1000 consecutive primary liver transplants under tacrolimus: Story of success and failure with mean follow up of seven years. 119th American Surgical Association. San Diego, CA, April 1999.
168
M Zak, AB Jain, B Yelochan, L Kingery, K Nestler, CA Youk, JJ Fung. Comparative incidence of de novo non-lymphoid malignancies following liver transplantation under tacrolimus using surveillance epidemiologic end-result data. 2nd International Transplant Coordinators Society Meeting, Maastricht, Netherlands. April 1999.
169
M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. 2nd International Transplant Coordinators Society Meeting, Maastricht, Netherlands. April 1999.
170
M Funovits, AB Jain, A DiMartini, N Rishi, MG Fitzgerald, S Rohal, JJ Fung. Long-term results of liver transplantation for alcohol-related liver disease under tacrolimus. 2nd International Transplant Coordinators Society Meeting, Maastricht, Netherlands. April 1999.
171
D Brody, AB Jain, I Hamad, L Kingery, K Nestler, C Hartner, JJ Fung. Use of neural for post- liver transplant neurological complications under tacrolimus. 2nd International Transplant Coordinators Society Meeting, Maastricht, Netherlands. April 1999
172
A Rafail, AB Jain, L Kingery, K Nestler, C Hartner, J McCauley, R Kashyap, JJ Fung. Incidence of end-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: Adults and children. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, and the Netherlands. April 1999.
173
D Brody, AB Jain, I Hamad, S Rohal, K Nestler, C Hartner, JJ Fung. Prospective randomized trial of tacrolimus and steroid versus tacrolimus, steroid, and Mycophenolate Mofetil in primary liver transplant. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, Netherlands. April 1999.
174
B Yelochan, AB Jain, M Funovits, K Nestler, C Hartner, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than eight years’ actual follow-up. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, The Netherlands. April 1999
175
A Rafail, AB Jain, AK Singhal, L Kingery, K Nestler, JJ Fung. Long-term impact of positive cross match due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus in adults and children. M Funovits, AB Jain, I Hamad, B Yelochan, JJ Fung, K Nestler, C Hartner, S Kusne. Cytomegalovirus infection in liver transplant recipients: Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy. International Transplant Coordinator’s Society Meeting, Maastricht, Netherlands. April 1999.
176
S Rohal, AB Jain, K Iurlano, C Gronsky, K Nestler, J Reyes, JJ Fung. Primary liver transplant under tacrolimus: 1000 consecutive cases: mean follow up seven years.
177
N Marino, AB Jain, L Kingery, K Nestler, C Hartner, JJ Fung. Prospective study of pregnancy following liver transplantation under tacrolimus. International Transplant Coordinator’s Society Meeting, Maastricht, Netherlands. April 1999.
178
J Rogers, AB Jain, M Devera, B Yelochan, J Rakela, JJ Fung. Long-term outcome of hepatitis C viral infection in primary adult liver transplant recipients compared to non-HCV under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S15, 1999.
179
A Doria, AB Jain, I Marino, S Gruttadauria, VL Scott, JJ Fung. Conversion from tacrolimus to Cyclosporine A following primary liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S32, 1999.
180
G Burkhart, R Frye, R Branch, R Venkataramanan, T McKaveney, R Hammond, C Rosenberg, JJ Fung, AB Jain. Drug metabolism in older OLTx patients: Effects of donor and recipient age. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7):S145, 1999.
181
AB Jain, JJ Fung, S Todo, J Rakela, J Demetris, S Iwatsuki, TE Starzl. More than six years’ actual follow up: Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S197, 1999.
182
AB Jain, A DiMartini, N Rishi, MG Fitzgerald, S Rohal, J Rakela, JJ Fung. Long-term results of liver transplantation for alcoholic-related liver disease under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S765, 1999.
183
AB Jain, AK Singhal, J Reyes, J Rakela, JJ Fung. Long-term impact of positive cross match due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S198, 1999.
184
J McCauley, AB Jain, I Hamad, JJ Fung. Acute renal failure requiring dialysis in liver transplant recipients under tacrolimus, Prednisone versus tacrolimus, Prednisone, and CellCept. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S201, 1999.
185
M Devera, AB Jain, A Tasamandas, J Rogers, J Rakela, JJ Fung. Long-term effect of Interferon- Alpha for HCV infection in post-liver transplantation: Actual seven-to-nine years’ follow-up. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S201, 1999.
186
AB Jain, G Mazariegos, K Iurlano, JJ Fung, J Reyes. Why some-children are still on steroids beyond five years post-liver transplantation under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S231, 1999.
187
AB Jain, J Reyes, G Mazariegos, T Cacciarelli, R Kashyap, M Nalesnik, S Rohal, JJ Fung. Incidence of post-transplant lymphoproliferative disorder in adults and children: Consecutive 1000 primary liver transplant recipients under tacrolimus. 18th Annual Meeting of the American Society of Transplantation (AST), May 15-19, 1999. Chicago, IL, 1999. Abstract: Transplantation 67(7): S246, 1999.
188
AB Jain, K Blakomer, JJ Fung. Post-transplant lymphoproliferative disorder (PTLD) following adult liver transplantation: Retrospective study of over 4000 patients over 15 years from a single center. 25th Annual Scientific Meeting, American Society of Transplant Surgeons (ASTS), Chicago, IL, Transplantation 67(9); S587, 1999.
189
JR Madariaga, AB Jain, G Costa, J Reyes, G Mazariegos, SF Dodson, J Rakela, JJ Fung. Hepatic artery complications following primary liver transplantation in adults and children: 1000 consecutive cases under tacrolimus. 25th Annual Scientific Meeting, American Society of Transplant Surgeons (ASTS), Chicago, IL, Transplantation 67(9); S599, 1999.
190
AB Jain, S Rohal, J Madariaga, K Abu-Elmagd, SF Dodson, J Rakela, JJ Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. 25th Annual Scientific Meeting, American Society of Transplant Surgeons (ASTS), Chicago, IL, Transplantation 67(9); S601, 1999.
191
AB Jain, G Mazariegos, K Iurlano, JJ Fung. J Reyes. Under tacrolimus, why some children are still on steroids beyond five-year post-liver transplantation. Fifth Congress of the International Liver Surgery. 5(4); C-13, 12A, 1999.
192
AB Jain, S Rohal, J Madariaga, K Abu-Elmagd, SF Dodson, J Rakela, JJ Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. Fifth Congress of Transplantation and Surgery. 5(4); C-4, 12B, 1999.
193
AB Jain, JJ Fung, I Hamad, S Zuckerman, D Venkataramanan. Use of Mycophenolate Mofetil for tacrolimus-related chronic nephrotoxicity in liver transplant recipients. Fifth Congress of the Transplantation and Surgery. 5(4); C-4, 13, 1999.
194
AB Jain, J Reyes, G Mazariegos, T Cacciarelli, R Kashyap, M Nalesnik, S Rohal, JJ Fung. Post- transplant lymphoproliferative disorder in adults and children: Consecutive 1000 primary liver transplant recipients under tacrolimus. Fifth Congress of the International Liver Transplantation Society,
195
AB Jain, K Blakemere, JJ Fung, P Randhawa, SF Dodson, J Rakela, M Nalesnik. Incidence of post-transplant lymphoproliferative disorder (PTLD): Retrospective study of over 4000 adults after liver transplantation 15-years’ experience from a single center. Fifth Congress of the International Liver Surgery. 5(4); C-8, 27B, 1999.
196
AB Jain, I Hamad, SF Dodson, D Kramer, J Rakela, A Demetris, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus and Mycophenolate Mofetil in primary PA, August 26-28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-25, 97, 1999.
197
AB Jain, I Hamad, M Funovits, JJ Fung. Detection of early antigenemia (p-g65) in peripheral blood leukocytes and pre-emptive therapy for Cytomegalovirus infection in liver transplant recipients. Abstract: Liver Transplantation and Surgery. 5(4); C-35, 135, 1999.
198
J Reyes, AB Jain, G Mazariegos, R Kashyap, JJ Fung. Conversion of pediatric liver allograft recipients from Cyclosporin to tacrolimus for acute and chronic rejection: mean seven years’ follow up. Abstract: Liver Transplantation and Surgery. 5(4); C-38, 147, 1999.
199
J Reyes, AB Jain, G Mazariegos, R Kashyap, T Cacciarelli, N Rishi, JJ Fung. Comparative study: Primary liver transplantation in children under tacrolimus and Cyclosporine. Fifth Congress of the Transplantation and Surgery. 5(4); C-38, 148, 1999.
200
AB Jain, l AK Singhal, J Reyes, J Rakela, JJ Fung. Impact of positive crossmatch due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus in the long term. Fifth Congress Transplantation and Surgery. 5(4); C-26, 99, 1999.
201
G Burckart, R Frye, R Branch, R Venkataramanan, T McKaveney, R Hammond, C Rosenberg, J.J Fung, A B Jain. Drug metabolism in older OLTx patients: Effects of donor and recipient age. Fifth Abstract: Liver Transplantation and Surgery. 5(4); C-27, 104, 1999.
202
AB Jain, J Reyes, R Kashyap, N Rishi, S Rohal, J Rakela, JJ Fung. Primary liver transplant under tacrolimus in infants, children, adults, and seniors: 1000 consecutive cases: Mean followup seven 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-27, 103, 1999.
203
AB Jain, J McCauley, R Kashyap, A Rafail, JJ Fung. End-stage renal failure amongst long-term survival of primary liver transplant recipients under tacrolimus: Adults and children. Fifth Congress of Transplantation and Surgery. 5(4); C-27, 105, 1999.
204
A Doria, AB Jain, I Marino, S Gruttadauria, V Scott, JJ Fung. Conversion from tacrolimus to Cyclosporine A following primary liver transplantation under tacrolimus. Fifth Congress of the Transplantation and Surgery. 5(4); C-28, 106, 1999.
205
S Agarwal, E Culligan, AB Jain, P Chakrabarti, G Matzke, J McCauley, R Shapiro, G Burckart, M Virji, R Venkataramanan. Assessment of renal function in liver and renal transplant patients. Fifth Abstract: Liver Transplantation and Surgery. 5(4); C-28, 107, 1999.
206
J Pisupati, AB Jain, S Zuckerman, I Hamad, J Lever, R Venkataramanan. Time-dependent changes in the kinetics of Mycophenolate acid (MPA) in liver transplant patients. Fifth Congress of the Transplantation and Surgery. 5(4); C-30, 114, 1999.
207
R Venkataramanan, AB Jain, I Hamad, S Mehta, V Warty, JJ Fung. Mycophenolate Mofetil has no effect on tacrolimus pharmacokinetics in liver transplant patients. Fifth Congress of the International Surgery. 5(4); C-30, 116, 1999.
208
J Rogers, AB Jain, M Devera, B Yelochan, J Rakela, JJ Fung. Outcome of hepatitis C viral (HCV) infection in primary adult liver transplant recipients compared to non-HCV under tacrolimus. Abstract: Liver Transplantation and Surgery. 5(4); C-33, 128, 1999.
209
M Devera, AB Jain, A Tasamandas, J Rakela, JJ Fung. Results of Interferon-Alpha for HCV infection post-liver transplantation: Results after actual five-to-seven years’ follow up. Fifth Congress of Transplantation and Surgery. 5(4); C-33, 129, 1999.
210
AB Jain, JJ Fung, J Reyes, R Venkataramanan. Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pediatric and adult liver transplant recipients. Fifth Abstract: Liver Transplantation and Surgery. 5(4); C-39, 150, 1999.
211
AB Jain, J Madariaga, G Costa, J Reyes, G Mazariegos, SF Dodson, J Rakela, JJ Fung. Rate of hepatic artery complication following primary liver transplantation in adults and children: 1000 consecutive cases under tacrolimus. Fifth Congress of the International Liver Transplantation Society, 1999.
212
J McCauley, AB Jain, I Hamad, JJ Fung. Post-operative acute renal failure in liver transplant recipients under tacrolimus, Prednisone versus tacrolimus, Prednisone, and CellCept. Fifth Congress of Transplantation and Surgery. 5(4); C-42, 163, 1999.
213
AB Jain, J Demetris, J Rakela, TE Starzl, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than six years’ actual follow-up. Fifth Congress of the Transplantation and Surgery. 5(4); C-49, 191, 1999.
214
A DiMartini, N Day, M Dew, T Lane, AB Jain. Outcome of liver transplantation in alcoholic 28, 1999. Abstract: Liver Transplantation and Surgery. 5(4); C-51, 198, 1999.
215
R Kashyap, AB Jain, B Carr, J Rakela, J Barnes, JJ Fung. Elevated serum alpha-fetoprotein among patients with end-stage liver disease and its clinical significance. Fifth Congress of the Transplantation and Surgery. 5(4); C-57, 222, 1999.
216
R Venkataramanan, J Ou, S Zuckerman, J Pisupati, AB Jain. Does plasma protein binding of Mycophenolate acid affect its clearance? Fifth Congress of the International Liver Transplantation 231, 1999.
217
AB Jain, I Hamad, S Zuckerman, J Pisupati, R Venkataramanan, TE Starzl. The pharmacokinetics of oral tacrolimus in liver transplant patients: Study of intra-individual variation. Fifth Abstract: Liver Transplantation and Surgery. 5(4); C-59, 232, 1999.
218
S Agarwal, E Culligan, AB Jain, G Burckart, J McCauley, R Venkataramanan. Assessment of renal function in liver transplant patients. AAPS Annual Meeting in San Francisco, CA, November 1998.
219
S Agarwal, E Culligan, AB Jain, P Chakrabarti, J McCauley, R Shapiro, G Burckart, R Venkataramanan. Evaluation of renal function in renal transplant patients on tacrolimus therapy. USP, May 1999.
220
R Venkataramanan, AB Jain, et al. Pharmacokinetics of tacrolimus not altered by Mycophenolate Mofetil. International Therapeutic Drug Monitoring and Clinical Toxicology Meeting. Calne, Australia, September 1999.
221
R Venkataramanan, AB Jain, et al. Time-dependent changes in the kinetics of mycophenolic acid in liver transplant patients. International Therapeutic Drug Monitoring and Clinical Toxicology Meeting, Calne, Australia, September 1999.
222
J Pisupati, AB Jain, S Zuckerman, I Hamad, J Lever, G Burckart, R Venkataramanan. Time- dependent changes in the kinetics of mycophenolic acid (MPA) in liver transplant patients. American College of Clinical Pharmacology, Annual Meeting, Washington, DC, 1999.
223
J Pisupati, AB Jain, S Zuckerman, I Hamad, J Lever, G Burckart, R Venkataramanan. Time- dependent changes in the kinetics of mycophenolic acid in liver transplant patients. Annual AAPS Meeting. New Orleans, LA, November 1999.
224
S Agarwal, E Culligan, AB Jain, P Chakrabarti, J McCauley, R Shapiro, G Burckart, R Venkataramanan. Evaluation of renal function in renal transplant patients on tacrolimus therapy. Annual AAPS Meeting. New Orleans, LA, November 1999.
225
S Rohal, AB Jain, I Hamad, K Nestler, C Hartner, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids, and Mycophenolate Mofetil in primary adult liver transplantation. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
226
S Rohal, AB Jain, K Nestler, C Hartner, JJ Fung. Reasons for long-term steroid use following primary adult liver transplantation under tacrolimus. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
227
C Gronsky, AB Jain, J Reyes, K Iurlano, G Mazariegos, M Nalesnik, S Rohal, JJ Fung. Post- transplant lymphoproliferative disorder in adults and children: Consecutive 1000 primary liver transplant recipients. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
228
K Iurlano, AB Jain, C Gronsky, G Mazariegos, JJ Fung, J Reyes. Why some children are still on steroids beyond five-year post liver transplantation? The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
229
A Rafail, M Gadomski, AB Jain, K Nestler, JJ Fung. Conversion from Cyclosporine to tacrolimus for chronic liver allograft rejection: More than six years’ actual follow-up. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
230
L Boig, AB Jain, AK Singhal, D Stock, C Shay, A Rafail, S Rohal, JJ Fung. Impact of positive cross match due to IgG versus IgM antibodies in primary liver transplantation under tacrolimus in long term. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
231
M Zak, AB Jain, K Blakomer, JJ Fung, K Nestler, C Hartner, M Nalesnik. Post-transplant lymphoproliferative disorder (PTLD) following adult liver transplantation: Retrospective study of over 4000 patients over 15 years from a single center. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
232
C Shay, AB Jain, A DiMartini, D Stock, L Boig, S Rohal, JJ Fung. Liver transplantation for alcoholic-related liver disease under tacrolimus: Long-term results. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
233
N Marino, AB Jain, K Nestler, M Devera, JJ Fung. Results of Interferon-Alpha for HCV infection post-liver transplantation: Results after actual five-to-seven years’ follow up. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
234
B Yelochan, M Gadomski, AB Jain, JJ Fung. Use of Mycophenolate Mofetil for tacrolimus- related chronic nephrotoxicity in liver transplantation. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
235
J Flohr, AB Jain, E Molmenti, J Lignoski, D Good, JJ Fung. The Eighth Annual International Transplant Nurses Society Symposium and General Assembly. Toronto, Canada, September 9-11, 1999.
236
AB Jain, K Blakomer, R Kashyap, K Ruppert, S Rohal, TE Starzl, JJ Fung, J Demetris. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation (LTx)? Analysis of 6057 biopsies in 1055 LTx: Mean follow-up after six years’. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2, 1999. Abstract #601.
237
AB Jain, JJ Fung, R Kashyap, S Rohal, M Nalesnik. Comparative study of post-transplant lymphoproliferative disorder and de novo cancer after liver transplantation. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2; 173, 1999. Abstract #602.
238
AB Jain, K Blakemere, P Randhawa, R Kashyap, JJ Fung, M Nalesnik. Rate of post-transplant lymphoproliferative disorder (PTLD) under Cyclosporine and tacrolimus-based immunosuppression: Review of 4022 adult liver transplant patients. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2, 1999. Abstract #602.
239
J Rogers, AB Jain, M Devera, J Rakela, JJ Fung. Under tacrolimus’ outcome of hepatitis viral (HCV) infection in primary adult liver transplant recipients compared to non-HCV: Mean follow up of 93 months. 50th American Association for the Study of Liver Diseases, Dallas, TX, November 5-8, 1999. Abstract: Hepatology 30(4)2; 179A, 1999. Abstract #74.
240
AB Jain, K Blakemere, R Kashyap, S Rohal, TE Starzl, JJ Fung, J Demetris. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation (LTx)? Analysis of 5252 biopsies in 1055 LTx: Mean follow-up six years. Fourth International Conference on New Trends in Clinical and Experimental Immunosuppression, Geneva, Switzerland, 1999.
241
A.N Vats, R Shapiro, D Ellis, A Gautam, PS Randhawa, M Saxena, V Scantlebury, C Vivas, M Jordan, AB Jain, R Tadikamalla, K Weck. Development of quantitative PCR for BK virus detection in urine and its role in management of allograft viral infection masquerading as acute rejection. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Abstract: Transplantation 69(8) S136, 2000. Abstract #96.
242
P Chakrabarti, H Wong, A Toyofuku, V Scantlebury, M Jordan, C Vivas, AB Jain, J McCauley, J Johnston, P Randhawa, T Hakala, R Simmons, JJ Fung, TE Starzl. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Chicago, IL, May 13-20. Abstract: Transplantation 69(8) S224, 2000. Abstract #425.
243
AB Jain, J Reyes, G Mazariegos, R Kashyap, R Jaffe, JJ Fung, M Nalesnik. Rate of post- transplant lymphoproliferative disorders (PTLD) in children under Cyclosporine and tacrolimus: 766 Consecutive Recipients: 15 years’ experience. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Abstract: Transplantation 69(8)317, 2000. Abstract #787.
244
R Kashyap, AB Jain, J Reyes, AJ Demetris, JJ Fung. Causes of re-transplantation, rate, and survival after 4000 consecutive primary liver transplantations from a single center with 15 years’ median follow-up. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation, Chicago, IL, May 13-20, 2000. Abstract: Transplantation 69(8) S320, 2000.
245
Abstract # P-446.
246
AB Jain, AJ Demetris, R Kashyap, TE Starzl, JJ Fung. Survival patterns after live transplantation: Effect of age, gender, and era in 4000 consecutive patients from a single center with 15- 6-8, 2000.
247
G Costa, AB Jain, J Madariaga, J Reyes, G Mazariegos, R Kashyap, JJ Fung. Bile duct complications following liver transplantation in adults and children: 1000 consecutive patients. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #57.
248
M Giraldo, AB Jain, D Martini, SF Dodson, JJ Fung. Outcome of liver transplantation for hemophiliacs and HCV, with or without HBV and HIV infection under tacrolimus: Nine years’ experience from a single center. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #94.
249
AB Jain, K Blakomer, R Kashyap, K Ruppert, S Rohal, TE Starzl, JJ Fung, J Demetris. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx): Review of 5252 biopsies in 1055 LTx mean follow-up—Six years. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #105.
250
AB Jain, R Kashyap, J Reyes, AJ Demetris, JJ Fung. Causes of death after liver transplantation (LTx) in 4000 consecutive patients: Median follow-up—15-years. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #110.
251
R Kashyap, AB Jain, J Reyes, AJ Demetris, JJ Fung. Causes of re-transplantation after 4,000 consecutive primary liver transplantations from a single center with 15-year median follow-up rate and survival. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23- 23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #112.
252
AB Jain, JJ Fung, R Kashyap, S Rohal, M Nalesnik. Incidence of de novo cancer and post- transplant lymphoproliferative disorder (PTLD) after liver transplantation under tacrolimus: Comparative study. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #129.
253
AB Jain, J Reyes, G Mazariegos, R Kashyap, R Jaffe, M Green, JJ Fung, M Nalesnik. Under Cyclosporine and tacrolimus’ rate of post-transplant lymphoproliferative disorders (PTLD) in children: 766 consecutive recipients’ 15-years’ experience. International Liver Transplantation Society Sixth Congress. Buenos Aires, Argentina, June 23-23, 2000. Abstract: Liver Transplantation 6(3), 2000. Abstract #131.
254
AB Jain, G Mazariegos, R Kashyap, et al. Pediatric liver transplantation in 808 consecutive children: 18 years-experience from a single center. First Congress of the International Pediatric Transplant Association. Venice, Italy, August 23-25, 2000.
255
AB Jain, J Reyes, G Mazariegos, R Kashyap, et al. Comparison of post-transplant lymphoproliferative disorders (PTLD) in children under Cyclosporine and tacrolimus: 766 consecutive recipients: 15-year experience. First Congress of the International Pediatric Transplant Association. Venice, Italy, August 23-25, 2000.
256
R Kashyap, AB Jain, AJ Demetris, SF Dodson, D Kramer, JJ Fung. Rate and causes of re- transplantation with survival after 4000 primary liver transplantations from a single center: Two-to-19 years’ follow-up. XVII International Congress of the Transplantation Society. Rome, Italy, August 27 – September 1, 2000.
257
AB Jain, R Kashyap, AJ Demetris, SF Dodson, TE Starzl, JJ Fung. Causes of death after liver transplantation (LTx) in 4000 consecutive patients: Follow-up two-to-19 years. XVII International Congress of the Transplantation Society. Rome, Italy, August 27 – September 1, 2000.AB Jain, R Kashyap, SF Dodson, D Kramer, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary liver transplant: A complete report. XVII International Congress of the Transplantation Society. Rome, Italy, August 27 – September 1, 2000.
258
N Harpur, AB Jain, T Grogan, T Morris, K Emmet, JJ Fung. Incidence of de novo cancer and post-transplant lymphoproliferative disorder (PTLD) after liver transplantation under tacrolimus: Comparative study. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.
259
D Stock, AB Jain, L Boig, C Shay, JJ Fung. Experience of liver transplantation in patients with human immunodeficiency virus type I (HIV). Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.
260
C Gronsky, AB Jain, K Iurlano, A Smith, G Mazariegos, JJ Fung. Under Cyclosporine and tacrolimus’ rate of post-transplant lymphoproliferative disorders (PTLD) in children: 766 Consecutive recipients: 15-year’ experience. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.
261
K Emmett, AB Jain, T Morris, T Grogan, N Harpur, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids and Mycophenolate Mofetil in primary liver transplantation: A complete report. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.
262
T Grogan, AB Jain, T Morris, K Emmett, N Harpur, JJ Fung. Survival patterns after liver transplantation: Effect of age, gender, and era in 4000 consecutive patients from a single center with two-to-18 years’ follow-up. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.
263
T Morris, AB Jain, T Grogan, K Emmett, N Harpur, JJ Fung. Causes of re-transplantation after 4000 consecutive primary liver transplantations from a single center with two-to-18 years’ follow-up. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.
264
T Morris, AB Jain, K Emmett, S Rohal, T Grogan, N Harpur, JJ Fung. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation (LTx)? Analysis of 5252 biopsies in 1048 LTx—Mean follow-up: Six years. Ninth ITNS Symposium and General Assembly. Las Vegas, NE, September 7-10, 2000.
265
AB Jain, R Kashyap, S Potdar, JJ Fung. Question of steroid withdrawal under tacrolimus for primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) after liver transplantation and long-term survival. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.
266
AB Jain, V Scantlebury, V Garrido, P Chakrabarti, R Shapiro, RJ Corry. Use of Rapamycin in pancreatic transplantation under tacrolimus-based immunosuppression. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.
267
AB Jain, R Kashyap, SF Dodson, A Khan, O Shakil, JJ Fung. Need for ribavirin dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplantation. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.
268
AB Jain, R Kashyap, JJ Fung. Role of Mycophenolate Mofetil (MMF) in liver transplantation (LTx) for HCV-related end-stage liver failure (a prospective randomized trial). Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.
269
AB Jain, G Mazariegos, R Kashyap, C Doria, M Nalesnik, J Reyes. Comparison of post- transplant lymphoproliferative disorders (PTLD) in children under Cyclosporine and tacrolimus: 766 consecutive recipients: 15-year experience. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.
270
AB Jain, R Kashyap, S Potdar, JJ Fung, J Reyes. Pediatric liver transplantation in 808 consecutive children: 1830 years experience from a single center. Transplant 2001--The Second Joint American Transplant Meeting, Chicago, IL, May 12-16, 2001.
271
J Reyes, AB Jain, G Mazariegos, R Kashyap, K Iurlano, JJ Fung, TE Starzl. Pediatric liver transplantation in 808 consecutive children: 18 years’ experience from a single center. Poster 2001.
272
AB Jain, J Reyes, R Kashyap, J Mazariegos, B Eghtesad, JJ Fung, TE Starzl. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx) in children and adults in long-term follow-up. Poster presentation at the Festschrift Honoring Thomas E. Starzl, M.D., Ph.D.
273
AB Jain, R Kashyap, SF Dodson, I Hamad, B Eghtesad, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids, and Mycophenolate Mofetil in primary liver transplantation. Poster presentation at the Festschrift Honoring Thomas E. Starzl, M.D., Ph.D.
274
AB Jain, G Mazariegos, R Kashyap, JJ Fung, TE Starzl, J Reyes. Absence of chronic rejection under tacrolimus in pediatric liver transplant recipients: Mean follow-up of nine years. Poster at the Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6) C-47; 2001. Abstract #185.
275
AB Jain, G Mazariegos, R Kashyap, K Iurlano, JJ Fung, J Reyes. Pediatric Liver Transplantation in 808 consecutive children: 18 years’ experience from a single center. Poster at the Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6) C-78; 2001. Abstract #312.
276
I Daly, AB Jain, R Kashyap, JJ Fung, J Reyes. Use of Mycophenolate Mofetil (MMF) for chronic rejection in liver allograft under tacrolimus. Oral presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6) C-83; 2001. Abstract #330.
277
R Kashyap, AB Jain, A Demetris, S Kusne, J Fridell, E Asham, JJ Fung. Incidence and outcome of cytomegaloviral (CMV) hepatitis in adult post-liver transplant allograft under tacrolimus. Oral presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6) C-14; 2001. Abstract #54.
278
AB Jain, R Kashyap, B Eghtesad, G Costa, JJ Fung. The question of steroid withdrawal under tacrolimus for primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) after liver transplantation and long-term survival. Poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6) C-51; 2001. Abstract #228.
279
AB Jain, R Kashyap, B Eghtesad, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6) C-5; 2001. Abstract #19.
280
AB Jain, R Kashyap, B Eghtesad, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Poster presentation. Seventh International Liver Transplantation Society Meeting ELTA, Berlin, Germany, July 11-13, 2001. Liver Transplantation 7(6) C-33; 2001. Abstract #130.
281
AB Jain, R Kashyap, A Khan, S Obaid, JJ Fung. Need for ribavirin-dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. Poster presentation. Poster presentation. Hepatitis Single Topic Conference: New Therapeutic Strategies for Hepatitis C. Chicago, IL, June 15-16, 2001.
282
L Boig, AB Jain, M Funovits, B Yelochan, N Marino, C Shay, M Gadomski, D Stock, K Nestler, L King, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Rate of post-transplant lymphoproliferative disorder under Cyclosporine (CsA) and tacrolimus (TAC) after liver transplantation (LTx) in adults and children. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.
283
N Marino, AB Jain, B Yelochan, M Funovits, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Survival patterns post-liver transplantation: Effect of age, general and era in consecutive 4000 patients with median 15 years’ follow-up from the single center. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22- 27, 2001.
284
B Yelochan, AB Jain, N Marino, M Funovits, M. Gadomski, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Longitudinal follow-up after liver transplantation with hepatic C viral infection. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.
285
B Yelochan, AB Jain, D Stock, L Boig, C Shay, N Marino, M Funovits, M Gadomski, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Prospective randomized trial of tacrolimus and steroid vs. tacrolimus, steroid, and Mycophenolate Mofetil in primary liver transplantation. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.
286
L Boig, AB Jain, M Funovits, B Yelochan, N Marino, C Shay, M Gadomski, D Stock, K Nestler, L King, S Rohal, C Hartner, A Rafail, E. Kallenborn, K Newell. Surgical/Non-surgical, immunological/non-immunological, early and late complications after primary liver transplantation: analyses of 1000 consecutive patients with 8-11 years’ follow up. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.
287
M Funovits, AB Jain, B Yelochan, N Marino, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx) in children and adults in long-term follow-up. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.
288
M Funovits, AB Jain, B Yelochan, N Marino, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Incidence and outcome of cytomegaloviral (CMV) hepatitis in adult post-liver transplant allograft under tacrolimus. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.
289
N Marino, AB Jain, B Yelochan, M Funovits, M Gadomski, B Flynn, K Nestler, L Kingery, S Rohal, C Hartner, A Rafail, E Kallenborn, K Newell. Question of steroid withdrawal under tacrolimus for primary biliary cirrhosis (PBC) primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) after liver transplantation and long-term survival. The 3rd Congress of the International Transplant Coordinators Society, Nagoya, Japan, July 22-27, 2001.
290
D. Stock, AB Jain, L Boig, C. Shay, M. Gadomski, K. Nestler, L. Kingery, S. Rohal, M. Funovits, C. Hartner, B. Yelochan, A. Rafail, N. Marino, E. Kallenborn, K. Newell. Longitudinal follow-up after liver transplantation with hepatic C viral infection. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29- September 1, 2001.
291
A Smith, AB Jain, C Gronsky, K Iurlano, G Mazariegos, JJ Fung, J Reyes. Total absence of chronic rejection under tacrolimus in pediatric liver transplant recipient: Mean follow-up of nine years. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.
292
A Byerly, K Risch, AB Jain, M Pampena, T Morris, B Flynn, ST Grogan, K Emmett, N Harpur, JJ Fung. Role of Mycophenolate Mofetil (MMF) in Liver Transplantation (LTx) for HCV-related end- stage liver failure (a prospective, randomized trial). International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.
293
M Gadomski, K Nestler, AB Jain, L Kingery, S Rohal, M Funovits, C Hartner, B Yelochan, A Rafail, N Marino, M Zak, JJ Fung. Use of Rituximab (Chimeric Anti CD20 Antibody) in post-transplant lymphoproliferative disorder after liver, kidney, and pancreas transplantation. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.
294
K Risch, A Byerly, AB Jain, M Pampena, T Morris, B. Flynn, ST Grogan, K Emmett, N Harpur, JJ Fung. Incidence and outcome of cytomegaloviral (CMV) hepatitis in adult post liver transplant allograft under tacrolimus. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001.
295
K Nestler, AB Jain, B Flynn, S Rohal, M Gadomski, L Kingery, M Funovits, C Hartner, B Yelochan, A Rafail, N Marino, E Kallenborn, K Newell. Need for Ribavirin dose adjustment in relation to renal function for treatment of recurrent HCV infection in post-liver transplant patients. International Transplant Nurses Society, ITNS 10th Anniversary Symposium, Churchill College, Cambridge, England, August 29-September 1, 2001
296
AB Jain, R Kashyap, I Hamad, B Eghtesad, S Potdar, A Khan, JJ Fung. Prospective randomized trial of tacrolimus and steroids versus tacrolimus, steroids, and Mycophenolate Mofetil in primary liver transplantation. Poster presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.
297
AB Jain, R Kashyap, J Roberts, S Obaid, A Khan, JJ Fung. Longitudinal follow-up after liver transplantation (LTx) with hepatitis C viral infection. Oral presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.
298
AB Jain, J Reyes, R Kashyap, B Eghtesad, S Potdar, JJ Fung. Tacrolimus offers virtual freedom from chronic rejection after primary liver transplantation (LTx) in children and adults in long-term follow-up. Oral presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.
299
AB Jain, R Venkataramanan, R Kashyap, S Rohal, JJ Fung. Profound interaction between tacrolimus and protease inhibitor drugs in liver transplant patients (LTx). Oral presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.
300
AB Jain, J Reyes, R Kashyap, G Mazariegos, M Nalesnik, JJ Fung. Rate of post-transplant lymphoproliferative disorder under Cyclosporin (CsA) and tacrolimus (TAC) after liver transplantation (LTx) in adults and children. Poster presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001.
301
AB Jain, K Abu-Elmagd, R Kashyap, JW Marsh, V Scantlebury, RJ Corry, P Fontes, M Nalesnik, JJ Fung. Use of Rituximab (Chimeric anti-CD20 antibody) in post-transplant lymphoproliferative disorder (PTLD) after liver, kidney and pancreas transplantation. Poster presentation. Tenth ESOT Congress 2001. Lisbon, Portugal, October 6-11, 2001
302
AB Jain, G. Mazariegos, Randeep S. Kashyap, John J. Fung, Thomas E. Starzl, Jorge Reyes. Tacrolimus offers total absence of chronic rejection in pediatric liver transplant recipients: Follow up of 7-10 years. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, 2001, p. 246A. Abstract #292.
303
AB Jain, Randeep S. Kashyap, K. Abu-Elmagd, P. A. Fontes, J.J. Fung, M. Nalesnik. Use of Rituximab (chimeric anti-CD20 antibody) in post-transplant lymphoproliferative disorder (PTLD) after liver transplantation. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, p. 285A, 2001. Abstract #452.
304
R.S. Kashyap, AB Jain, J.J. Fung. Impact of cytomegaloviral (CMV) hepatitis in adult post liver transplant allograft under tacrolimus. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2, p. 285A, 2001. Abstract #453.
305
AB Jain, R.S. Kashyap, B. Eghtesad, S. Obaid, V. Ramesh, K. Akhtar, J.J. Fung. Ribavirin Dose Adjustment in relation to renal function is mandatory for treatment of recurrent HCV infection in post- liver transplant patients. The Liver Meeting 2001, The American Association for the Study of Liver Diseases 52nd Annual Meeting, Dallas, Texas, November 9-13, 2001. Hepatology 34(4):2 p. 409A, 2001. Abstract #947.
306
AB Jain, G Mazariegos, RS Kashyap, JJ Fung, J Reyes. Pediatric Liver Transplantation in 808 Consecutive children: 20 Years’ Experience from a Single Center. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.
307
AB Jain, RS Kashyap, B Eghtesad, PA Fontes, M Gadomski, M Nalesnik, JJ Fung. Use of Rituximab (Chimeric Anti-CD20 Antibody) in Post-Transplant Lymphoproliferative Disorder (PTLD) After Liver Transplantation (LTx). The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.
308
AB Jain, RS Kashyap, B Eghtesad, E Asham, JJ Fung. Role of Mycophenolate Mofetil (MMF) in Liver Transplantation (LTx) for HCV-Related End-Stage Liver Failure (A Prospective Randomized Trial. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.
309
R Shapiro, MC Jordan, VP Scantlebury, C Vivas, AB Jain, P Randhawa, J McCauley, JR Johnston, S Fedorek, E Gray, I Dvorchik, J Donaldson, JJ Fung, TE Starzl. A Pilot Trial of Tacrolimus and Sirolimus in Renal Transplantation. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.
310
I Daly, AB Jain, RS Kashyap, JJ Fung. Use of Mycophenolate Mofetil (MMF) for Chronic Rejection in Liver Allograft under Tacrolimus. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.AB Jain, G. Mazariegos, RS Kashyap, JJ Fung, TE Starzl, J Reyes. Absence of Chronic Rejection under Tacrolimus in Pediatric Liver Transplant Recipients: Mean Follow Up of Nine Years. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.
311
AB Jain, RS Kashyap, B Eghtesad, J Fridell, JJ Fung. Question of Steroid Withdrawal Under Tacrolimus for Primary Biliary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC), and Autoimmune Hepatitis (AIH) After Liver Transplantation and Long-Term Survival. The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.
312
AB Jain, R Venkataramanan, JJ Fung. Profound Interaction between Tacrolimus Anti-HIV Drugs in Liver Transplant Patients (LTx). The 2nd International Congress on Immunosuppression, San Diego, CA, December 6-8, 2001.
313
AB Jain, R. Pokhara, Jorge D. Reyes, M Nalesnik, TV Cacciarelli, JJ Fung, TE Starzl. Incidence of Post-Transplant Lymphoproliferative Disorder (PTLD) Among Liver Transplant Recipients in Adults and Children under Cyclosporine and Tacrolimus Therapy: 20-Years’ Experience from a Single Center. 122nd Annual Meeting of the American Surgical Association, The Homestead, Hot Springs, VA, April 25-27, 2002.
314
ME Devera, B Eghtesad, AB Jain, SF Dodson, JJ Fung, CA Bonham. Liver Transplantation in Patients Co-Infected with HIV and Hepatitis C. American Transplant Congress (ATC), Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transplant 2; (Suppl 3):139, Abstract #5.
315
B Eghtesad, SF Dodson, AB Jain, O Shakil, CA Bonham, PA Fontes, TV Cacciarelli, DA Geller, JW Marsh, R Pokharna, JJ Fung. Prevention of Recurrent Hepatitis B Virus after Liver Transplantation with Restricted Elimination of Hepatitis B Immune Globulin. American Transplant Congress (ATC), Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transplant 2; (Suppl 3):140, Abstract #11.
316
AB Jain, R. Venkataramanan, R Shapiro, VP Scantlebury, S Potdar, CA Bonham, M Ragni, JJ Fung. The Interaction between Anti-Retroviral Agents and Tacrolimus in Liver and Kidney Transplant Patients. American Transplant Congress (ATC), Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transplant 2: (Suppl 3):234, Abstract #385
317
JA Fridell, AB Jain, R Biederman, JD Reyes, R Sindhi, GV Mazariegos. Causes of Mortality beyond One Year Following Pediatric Liver Transplant under Tacrolimus. American Transplant Congress (ATC), Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transplant 2(Suppl 3):295, Abstract #625.
318
AB Jain, R Pokhara, GV Mazariegos, M Parizhskaya, R Jaffe, JJ Fung, JD Reyes. Tacrolimus Offers Almost Total Absence of Chronic Rejection in Pediatric Liver Transplant Recipients: Follow-Up of 7-10 Years. American Transplant Congress (ATC), Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transplant 2: (Suppl 3):352, Abstract #853.
319
TV Cacciarelli, AB Jain, JJ Fung, MA Nalesnik. The Impact of EBV-Negative Post-Transplant Lymphoproliferative Disorder on Survival in Adult and Pediatric Solid Organ Transplant Recipients. American Transplant Congress (ATC), Transplant 2002, Washington, DC, April 26-May 1, 2002. Am J Transplant 2; (Suppl 3):427, Abstract #1147.
320
AB Jain, R. Venkataramanan, B Eghtesad, R Shapiro, VP Scantlebury, S Potdar, CA Bonham, M Ragni, JJ Fung. The Interaction between Anti-Retroviral Agents and Tacrolimus in Liver and Kidney Transplant in HIV+ Patients. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C-6, Abstract #24.
321
JA Fridell, AB Jain, A Khan, E Asham, A Basu, JJ Fung, R Venkataramanan. Effect of T-Tube Clamping on Absorption of Rapamycin in Liver Transplantation Recipients. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C-6, Abstract #25.
322
AB Jain, R. Venkataramanan, JA Fridell, B Eghtesad, MV Ragni, JJ Fung. Nelfinavir, A Protease Inhibitor, Increases Sirolimus Levels in Liver Transplant Patients: A Case Report. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C-10, Abstract #37.
323
B Eghtesad, I Daly, B Broznck, DA Geller, PA Fontes, TV Cacciarelli, AB Jain, CA Bonham, SF Dodson, WJ Marsh, JJ Fung. Utilization of Livers from Non-Heart beating Donors (NHBD): A Single Center Experience. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C17, Abstract #66.
324
B Eghtesad, SF Dodson, AB Jain, O Shakil, CA Bonham, PA Fontes, TV Cacciarelli, DA Geller, JW Marsh, JJ Fung. Prevention of Recurrent Hepatitis B Virus After Liver Transplantation with Restricted Elimination of Hepatitis B Immune Globulin. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C-35, Abstract #138.
325
AB Jain, R Pokharna, K Abu-Elmagd, B Eghtesad, PA Fontes, M Gadomski, JJ Fung. Use of Rituximab (Chimeric Anti-CD20 Antibody) in Post-Transplant Lymphoproliferative Disorder (PTLD) After Liver Transplantation. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C-42, Abstract #168.
326
JA Fridell, AB Jain, JA Reyes, R Beiderman, R Sindhi, GV Mazariegos. Mortality Beyond One Year following Liver Transplant Under Tacrolimus Immunosuppression in Pediatric Patients. The Eighth Annual Congress of the International Liver Transplantation Society, Chicago, IL, June 13-15, 2002. Liver Transplantation 8(6): C-68, Abstract #272.
327
Corry R, Potdar S, Shapiro R, Scantlebury V, Randhawa P, AB Jain, McCauley J, Good D, Basu A, Fung JJ, Starzl TE. Pancreas and kidney-pancreas transplantation under a tolerogenic regimen of preconditioning with thyroglobulin and post-transplant tacrolimus. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #85.
328
AB Jain, Venkataramanan R, Shapiro R, Scantlebury V, Eghtesad B, Potdar S, Ragni M, Fung JJ. Profound interaction between tacrolimus, Rapamycin, and anti-HIV drugs in liver and kidney transplant patients. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #172.
329
Fridell JA, AB Jain, Reyes J, Beiderman R, Sindhi, Mazariegos GV. Causes of late mortality beyond one year following pediatric liver transplant under tacrolimus. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #392.
330
Pettiford B, Cacciarelli TV, Eghtesad B, AB Jain, Planinsic R, Reyes J, Fung JJ, Kormos RL. Simultaneous heart-liver transplantation: A worthwhile effort? XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #622.
331
Eghtesad B, Daly I, Broznck BA, Geller DA, Cacciarelli TV, Fontes PA, Bonham CA, Dodson SF, AB Jain, Marsh JW, Fung JJ. Utilization of livers from non-heart-beating donors (NHBD): A single- center experience. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #1664.
332
AB Jain, Scantlebury V, Shapiro R, Eghtesad B, Pokharna R, Reyes J, Potdar J, Flohr J, Fung JJ. Pregnancy post liver, kidney, and kidney + pancreas transplant under tacrolimus. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #2106.
333
AB Jain, Reyes J, Mazariegos G, Eghtesad B, Fontes PA, Cacciarelli TV, Marsh JW, De Vera ME, Rafail A, Starzl TE, Fung JJ. Pregnancy After Liver Transplantation Under Tacrolimus: A Single Center’s Experience Update at 13 Years. Presented at the XIX International Congress of The Transplantation Society, Miami, Florida. August 25-30, 2002.
334
Zak M, Bond GJ, Jain AB, Murase N, Canady J, Mazariegos G, Reyes J, Abu-Elmagd KM. De novo malignancy among intestinal allograft recipients. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #2710.
335
Basu A, AB Jain, Shapiro R, Scantlebury V, Potdar S, Jordan ML, Corry RJ. Safety and efficacy of low-dose thyroglobulin (rabbit anti-thymocyte globulin) for steroid-resistant rejection after pancreas transplantation under tacrolimus. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #2876.
336
Scantlebury V, Shapiro R, Jordan M, Corry R, Abu-Elmagd KM, Reyes J, Vivas C, Jain AB, Potdar S, Fung JJ, Starzl TE. The use of preconditioning and postoperative monotherapy in African American kidney and other organ recipients. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #3334.
337
Basu A, AB Jain, Horn E, Garrido V, Potdar S, Scantlebury V, Jordan ML, Shapiro R. Efficacy of low dose thyroglobulin versus OKT3 in steroid-resistant rejections (SRR) after kidney transplantation under tacrolimus. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #3340.
338
Shapiro R, Scantlebury VP, Jordan ML, Corry RJ, Potdar S, Jain AB, Vivas C, Randhawa P, Basu A, Smetanka C, Gray E, Murase N, Woodward J, Zeevi A, Demetris AJ, Fung JJ, Starzl TE. Kidney transplantation under a tolerogenic regimen of thyroglobulin preconditioning and post-transplant tacrolimus monotherapy. XIX International Congress of Transplantation Society, Miami, FL, August 25-30, 2002. Transplantation 74(4): Suppl, Abstract #3343.
339
Knapp D, Jain AB, Nestler K, Pampena ME, Harpur N, Coogan, T, Kurth V. Incidence of post- transplant lymphoproliferative disorder (PTLD) among liver transplant recipients in adults and children under cyclosporine and tacrolimus therapy: 20-year experience from a single center. The Art of Transplant Nursing 11th Annual Symposium and General Assembly, Westin Convention Center Hotel,
340
Flohr JM, Jain AB, Paynter M, Barber A, Bauder S, Orlofske, S, Good D. Primary oxalosis: A decade of experience after liver and kidney transplantation from a single center. The Art of Transplant PA, September 18-21, 2002.
341
James GL, Jain AB, Good D, Glidewell J, McCarthy D. Brautigam S, Flohr J. Use of Rapamycin in pancreatic transplantation under tacrolimus-based immunosuppression. The Art of Transplant Nursing September 18-21, 2002.
342
Kurth V, Jain AB, Knapp D, Pampena ME, Risch K, Emmett K, Nestler, K. More than ten years’ actual follow-up: Conversion from Cyclosporine (CyA) to tacrolimus for chronic liver allograft rejection. The Art of Transplant Nursing 11th Annual Symposium and General Assembly, Westin
343
James GL, Jain AB, Good D, Bonanza L, Peretic K, Paynter M, Flohr JM. Use of low-dose tacrolimus, Rapamycin, and steroids for primary combined kidney and pancreas transplantation. The Art of Transplant Nursing 11th Annual Symposium and General Assembly, Westin Convention Center
344
Pampena ME, Jain AB, Knapp D, Kurth V, Byerly A, Morris T, Kallenborn B. Surgical/non- surgical, immunological/non-immunological, early and late complications after primary liver transplantation. Analyses of 1,000 consecutive patients with 8-11 years’ follow-up. The Art of Transplant Nursing 11th Annual Symposium and General Assembly, Westin Convention Center Hotel,
345
Gadomski MR, Jain AB, Rohal S, Lewis MB, Funovits M, Yelochan B, Marino N. Profound interaction between tacrolimus, Rapamycin and anti-HIV drugs in liver and kidney transplant patients. The Art of Transplant Nursing 11th Annual Symposium and General Assembly, Westin Convention
346
Jain AB, Lecturer and Expert Panelist. Hepatocellular carcinoma: Advances in diagnosis and treatment. Hepatocellular Carcinoma Symposium, Institute Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT), Palermo, Italy, October 5, 2002.
347
Immunosuppression in liver Transplantation and role of Mycophenolate Mofetil: Liver Transplantation conference, Nagasaki Japan, April 10, 2003.
348
Jain AB, Raman Venkataramanan, Bijan Eghtesad, Amadeo Marcos, Margaret Ragni, Ron Shapiro, Ann B. Rafail, John J. Fung. Effect of Co-administered Lopinavir and Ritonavir (Kaletra) on Tacrolimus Blood Concentration in Liver Transplantation Patients. Liver Transplantation, Vol 9, No 9 (September), 2003: pp 954-960.
349
Bozorgzadeh A, Jain AB, Daller J, Ryan C, Sundrum U, Lansing K, Kaufmann D, Ornt D, Zand M, Betts R, Orloff M. Impact of hepatitis C viral (HCV) infection in primary cadaveric liver allograft v/s primarily living liver allograft in 100 consecutive liver transplant patients. 54th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, October 24-28, 2003. Abstract#770, Suppl 1, Hepatology. 34(4); pp.532A
350
Potdar S, Eghtesad E, Jain AB, Khan A, Malek S, Thai N, Sharma S, Patel K, Blisard D, Shapiro R, Fung J, and Starzl T. Comparison of Early Graft Function and Complications of Pancreas Transplant Recipients in Histidine-Tryptophan-Ketoglutarate (HTK) Solution. 9th Congress of the International Pancreas and Islet Transplant Association, July 8-11, 2003, Dublin Ireland, August 27, 2003. Transplantation 76(4); p. S-28 Abstract # 30, July 2003.
351
Potdar S, Martin J, Malek S, Thai N, Tublin M, Sharma S, Sharma S, Basu A, Jain AB, Shapiro S, Fung J, Starzl T. Percutaneous Ultrasound Guided Pancreas Allograft Biopsy Single Center Experience. Dublin Ireland, 9th Congress of the International Pancreas and Islet Transplant Association, July 8-11, 2003. Transplantation 76(4); p. S-29 Abstract # 035, August 27, 2003.
352
Potdar S, Shapiro R, Thai N, Jain AB, Sharma S, Randhawa P, Demetris A, Basu A, Marcos A, Fung J, Starzl T. Successful Reversal of Refractory Acute Rejection with Campath 1H in Pancreas Transplantation Recipients, 9th Congress of the International Pancreas and Islet Transplant Association, Dublin Ireland, July 8-11, 2003. Abstract#038 Transplantation 76(4); p.S-30, August 27, 2003.
353
Husain S, Potdar S, Jain AB, Malek S, Shapiro R, Wagener M, Kusne S, Fung J, Conditions Associated with Post-Operative Leukocytes Following Simultaneous Pancreas and Kidney (SPK) Transplantation, 9th Congress of the International Pancreas and Islet Transplant Association, Dublin Ireland, July 8-11, 2003. Transplantation 76(4); p. S-54 Abstract # 110, August 27, 2003.
354
Jain AB, Nalesnik MA, Reyes J, Pokharna R, Mazariegos GV, Cacciarelli TV, Marsch JW, Fontes PA, De Vera MA, Marcos A, Eghtesad B, Fung JJ. Lymphoproliferative Disorder (PTLD) In Children and Adults under Tacrolimus: 2,000 consecutive Liver Transplant Patients: 12 Years Experience. Post-Transplant. 9th Meeting of International Liver Transplant Society (ILTS). May 30 – June 4, 2003, Barcelona Spain. Liver Transplantation. June 2003, Vol 9 No 6. Abstract # 88, pp. C-22.
355
Jain AB, Venkataramanan R, Gadomski M, Eghtesad B, Marcos A, Fung JJ. Use of Mycophenolate Mofetil (MMF) for tacrolimus-related, chronic nephrotoxicity in post liver transplant (LTX) patients: long-term prospective trial with minimum six years follows up. 9th Meeting of International Liver Transplant Society (ILTS). May 30 – June 4, 2003, Barcelona Spain. Liver Transplantation. June 2003 Vol 9 No 6. Abstract # 169, pp. C-43.
356
Jain AB, Venkataramanan R, Eghtesad B, Marcos A, Ragni M, Shapiro R, Rafail A, Fung JJ. Profound drug interaction with a combination of two protease inhibitors (PI: Ritonavir and Lopinavir: Kaletra) and tacrolimus in post-liver transplant (LTX) patients with HIV infection. 9th Meeting of USA. Liver Transplantation. June 2003 Vol 9 No 6. Abstract # 323, pp. C-81.
357
Potdar S, Martin JA, Malek SK, Thai N, Tublin M, Sharma S, Basu A, Jain AB, Shapiro S, Fung JJ, Percutaneous ultrasound-guided pancreas allograft biopsy-single center experience. American Transplant Congress (ATC) May 30-June 4, 2003, Washington DC, American Journal of Transplantation. Suppl, 5 (3); pp. 253 Abstract#397.
358
Potdar S, Shapiro R, Thai N, Jain AB, Randhawa P, Demetris AJ, Basu A, Marcos A, Fung JJ, Successful Reversal of refractory Acute Rejection with Campath 1H in Pancreas Transplant Recipients. American Transplant Congress (ATC) May 30-June, 2003, Washington DC, Abstract # 670, American Journal of Transplantation. Suppl, 5. (3); pp. 324.
359
Kwak EJ, Jain AB, Ragni MV, Fung JJ, Kusne S. Infectious complications in recipients of liver transplantation co-infected with human immunodeficiency virus (HIV) American. American Transplant Congress (ATC) May 30-June, 2003, Washington DC, American Journal of Transplantation. Suppl.5. (3); pp. 433 Abstract#1100.
360
Eghtesad B, Broznck B, Kusum P, Sayeed M, Thomas C, Jain AB, De Vera ME, Fontes PA, Gayowski T, Marsh W, Marcos A, Fung J. Surgery, Comparison of Histidine-Tryptophan-Ketoglutarate (HTK) solution versus the university of Wisconsin (UW) solution for organ preservation in liver transplantation. American Transplant Congress (ATC) May 30-June, 2003, Washington DC. American Journal of Transplantation. Suppl. 5. (3); pp. 452 Abstract#1172.
361
Jain AB, Adel Bozorgzadeh, Randeep Kashyap, Kerrie Lansing, Mark Kelley, Mark Orloff. Use of Lamivudine Prophylaxis with a short course of hyperimmune hepatitis B Immunoglobulin (HBIg) for hepatitis B core antibody (HBcAb) positive liver allograft recipients who are hepatitis B surface antibody (HBsAb) and hepatitis B surface antigen (HBsAg) negative. Poster presentation at the 12th AASLD Hepatitis single topic conference, Chicago March 12- 13 2004.
362
Jain AB, Mark Orloff, Kerrie Lansing, Randeep Kashyap, Mark Kelley, Robert Betts, Marilyn Menegus, Adel Bozorgzadeh. Does valgan (Ganciclovir hydrochloride) provide effective prophylaxis against cytomegaloviral (CMV) infection in liver transplant recipients? Poster presentation at the EASL 2004 39th Annual Meeting Berlin Germany, April 14-18, 2004.
363
Adel Bozorgzadeh, Jain AB, Charlotte Ryan, Daniel Ornt, Martin Zand, Parvez Mantry, Kerrie Lansing, Mark Orloff. Cadaveric liver allograft versus living donor allograft for hepatitis C viral infection in 100 consecutive liver transplant recipients under tacrolimus: Single Center Experience. Oral presentation at the EASL 2004 39th Annual Meeting Berlin Germany, April 14-18, 2004.
364
Patrice Pfeiffenberger, Jain AB, Mary Gadomski, Leah Kingrey, Kathy Nestler, Ann Rafail. Use of Mycophenolate Mofetil (MMF) for tacrolimus-related, chronic nephrotoxicity in post liver transplantation (LTX) patients: Long-Term prospective trials with minimum six years’ follow up. Oral presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada.
365
Peggy Higby, Jain AB, Mary Gadomski, Leah Kingrey, Kathy Nestler, Ann Rafail. Effect of co- administered Lopinavir and Ritonavir (KALETRA®) on tacrolimus blood concentration in liver transplant patients. Oral presentation at the 13th Annual ITNS Symposium and General Assembly October 14-16, 2004 Vancouver, BC Canada.
366
Barb Yelochan, Jain AB, Peggy Higby, Nancy Marino, Anna Rafail. Value of ribavirin concentration measurement in plasma/blood in post liver transplant patients with hepatitis C virus (HCV) Infection. Oral presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada.
367
Mary Beth Lewis, Jain AB, Tahir Oruc, Atilla Soran, Peggy Higby, Ann Rafail Leah Kingery. review of the literature. Oral presentation at the 13th Annual ITNS Symposium and General Assembly October 14-16, 2004 Vancouver, BC Canada.
368
Joan Romano, Jain AB, Mark Orloff, Randeep Kashyap, Marilyn Menegus, Parvez Mantry, Charlotte Ryan, Joan Romano, Leah Bryan, Pam Batzold, Kerrie Lansing, and Adel Bozorgzadeh. Safety and efficacy profile of pegylated interferon 2 B (PEGINTRON) V/S pegylated interferon 2A (PEGASYS) in post liver transplant (LTx) hepatitis C virus (HCV) genotype1A/1B patients. Oral presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada.
369
Pam Batzold AB Jain, Mark Orloff, Randeep Kashyap , Pat Milot , Joan Romano , Leah Bryan , Jackie Cullen, Kerrie Lansing , Kari Burlee , Linda Merrick , Mary Vetter, Colleen Sober , Tomi Shisler, Kristen Wrobble and Adel Bozorgzadeh Liver Transplantation (LTx) for sarcoidosis: Question of recurrence. Poster presentation at the 13th Annual ITNS Symposium and General Assembly October 14- 16, 2004 Vancouver, BC Canada.
370
Jackie Cullen, AB Jain, Mark Orloff, Randeep Kashyap, Kerrie Lansing and Adel Bozorgzadeh. Should living donor liver graft be considered for retransplantation for recurrent hepatitis C? Oral presentation at the 13th Annual ITNS Symposium and General Assembly October 14-16, 2004 Vancouver BC Canada.
371
Linda Grinnell-Merrick, AB Jain, Mark Orloff , Randeep Kashyap, Kerrie Lansing and Adel Bozorgzadeh. Outcome of hepatic retransplantation in hepatitis C viral (HCV) positive subjects versus HCV negative subjects. Poster presentation at the 13th Annual ITNS Symposium and General Assembly October 14-16, 2004 Vancouver, BC Canada.
372
Kerrie Lansing, AB Jain, Mark Orloff, Kerrie Lansing, Randeep Kashyap, Mark Kelley, Robert Betts, Marilyn Menegus and Adel Bozorgzadeh High rate of symptomatic cytomegaloviral (CMV) infection with valgan (ganciclovir hydrochloride) prophylaxis in post-liver transplant recipients. Oral presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada.
373
Mary Vetter, AB Jain, Mark Orloff, Randeep Kashyap, Pat Milot, Joan Romano, Leah Bryan, Jackie Cullen, Kerrie Lansing, Kari Burlee, Linda Merrick, Pam Batzold, Colleen Sober, Tomi Shisler, Kristen Wrobble and Adel Bozorgzadeh. Hemochromatosis in males/females requiring liver transplantation and survival outcome. Oral presentation at the 13th Annual ITNS Symposium and General Assembly, October 14-16, 2004 Vancouver, BC Canada.
374
Leah A. Bryan, AB Jain, Adel Bozorgzadeh, Randeep Kashyap, Kerrie Lansing, Mark Kelley, Mark Orloff. Use of lamivudine prophylaxis with a short course of hyperimmune hepatitis B immunoglobin (HBIg) for hepatitis B core antibody (HBcAb) positive liver allograft recipients who are hepatitis B surface antibody (HBsAb) and hepatitis B surface antigen (HBsAg) negative. Poster presentation at the 13th Annual ITNS Symposium and General Assembly, October 14-16, 2004 Vancouver, BC Canada.
375
Tomi Elizabeth Shisler, Mark Kelley, AB Jain, Mark Orloff, Randeep Kashyap, Kristen Wrobble, Raman Venkataramanan and Adel Bozorgzadeh. changes in oral absorption of tacrolimus in post liver transplant patients before and after reversal of Jejunoileal (J-I) bypass: Case reports. Poster presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada.
376
Pam Batzold, AB Jain, Mark Orloff, Randeep Kashyap, and Adel Bozorgzadeh Use of Rapamycin in post-liver transplantation (LTx) for nephrotoxicity under calcineurin inhibitor. Oral presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada
377
Patricia M. Milot, Adel Bozorgzadeh, AB Jain, Charlotte Ryan, Daniel Orndt, Martin Zand, Parvez Mantry, Kerrie Lansing and Mark Orloff Living donor allograft versus cadaveric liver allograft for hepatitis C viral infection in 100 consecutive liver transplant recipients under tacrolimus: Single Center Experience. Poster presentation at the 13th Annual ITNS Symposium and General Assembly October 14-16, 2004 Vancouver, BC Canada.
378
Kristen Marie Wrobble, Bozorgzadeh, AB Jain, Kerrie Lansing, Randeep Kashyap and Mark Orloff Survival outcome after retransplantation for recurrent hepatitis C viral (HCV) infection. Oral presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada.
379
Mary E. Johnson, Adel Bozorgzadeh, AB Jain, Randeep Kashyap, Kerrie Lansing and Mark Orloff Survival outcome for hepatitis C recipients who received hepatitis B core antibody positive liver allograft. Oral presentation at the 13th Annual ITNS Symposium and General Assembly October 14-16, 2004 Vancouver, BC Canada.
380
Jackie Cullen, Adel Bozorgzadeh, AB Jain, Kerrie Lansing Randeep Kashyap and Mark Orloff Impact of the impact of older donor grafts in liver transplant (LTx) recipients with hepatic C viral (HCV) infection. Oral presentation at the 13th Annual ITNS Symposium and General Assembly. October 14-16, 2004 Vancouver, BC Canada.
381
AB Jain, Raman Venkataramanan, Bijan Eghtesad, Randeep Kashyap, Barbara Yelochan, Amadeo Marcos, John Fung. Value of ribavirin concentration measurement in plasma A/blood in post liver transplant patients with hepatitis C virus (HCV) infection. Poster presentation at the American Transplant Congress (ATC) May 14-19, 2004 Boston, MA.
382
AB Jain, J Reyes f, A Marcos, R. Kashyap, G Mazariegos, Bijan Eghtesad, W Marsh, P Fonte, M. Devera, J Fung. Surgical / Non-Surgical, Immunological / Non-Immunological, Early and Late complications after primary Liver Transplantation and its impact on graft and patient survival in adults and children. An analysis of 1000 consecutive patients with 9-12 years follow-up. Poster presentation at the American Transplant Congress (ATC) May 14-19, 2004 Boston, MA
383
Mark S. Orloff, Adel Bozorgzadeh, Kerrie E. Lansing, Jackie Cullen, Charlotte Ryan, AB Jain, David Waldman. Post-operative liver dysfunction following donations of segmental liver graft. American Journal of Transplantation 2004, Supp 8: Vol 4, P 532, Abstract # 1364.
384
AB Jain, Orloff M, Lansing K, Kashyap R, Kelley M, Betts R, Menegus M, Bozorgzadeh A. Valgan (ganciclovir hydrochloride) provides ineffective prophylaxis against cytomegaloviral (CMV) infection in liver transplant recipients. American Transplant Congress (ATC), May 15-19, 2004, Boston, Massachusetts, Abstract# 1499, American Journal of Transplantation Vol. 4. Supplement 8; pp.569.
385
Kelley M, AB Jain, Orloff M, Kashyap R, Wrobble K, Venkataramanan R, Bozorgzadeh A. Changes in oral absorption of tacrolimus post liver transplant patients before and after reversal of Jejunoileal (J-I) bypass: case reports. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 19, Liver Transplantation 10:6, June 2004.
386
Bozorgzadeh A, AB Jain, Lansing K, Kashyap R, Orloff M. Survival outcome after retransplantation for recurrent hepatitis c viral (HCV) infection. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 21, Liver Transplantation 10:6, June 2004.
387
Vetter M, AB Jain, Orloff M, Kashyap R, Milot P, Romano J, Bryan L, Cullen J, Lansing K, Burlee K, Merrick L, Batzold P, Sober C, Shisler T, Wrobble K, Bozorgzadeh A. Hemochromatosis in male/female requiring liver transplantation and survival outcome. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 22, Liver Transplantation 10:6, June 2004.
388
Ashok Jain, Jorge Reyes, Randeep Kashyap, Marcos Amadeo, Jorge Mazariegos, Bijan Eghtesad, Paulo Fontes, Tom Cacciarelli, Wallis Marsh, Mike Devera, John Fung. Early and late, Surgical/Non-surgical, immunological/non-immunological complications after primary liver transplantation and its impact on graft and patient survival in adults and children: An analysis of 1000 consecutive patients with > 10 years mean follow up. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 46, Liver Transplantation 10:6, June 2004.
389
AB Jain, Orloff M, Kashyap R, Lansing K, Bozorgzadeh A. Outcome of hepatic retransplantation in hepatitis c viral (HCV) positive subjects versus HCV negative subjects. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 65, Liver Transplantation 10:6, June 2004.
390
AB Jain, Orloff M, Lansing K, Kashyap R, Kelley M, Betts R, Menegus M, Bozorgzadeh A. High rate of symptomatic cytomegaloviral (CMV) infection with valgan (ganciclovir hydrochloride) prophylaxis in post-liver transplant recipients. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 77, Liver Transplantation 10:6, June 2004.
391
Cullen J, AB Jain, Orloff M, Kashyap R, Lansing K, Bozorgzadeh A. Should living donor liver graft be considered for retransplantation for recurrent hepatitis C? International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 105, Liver Transplantation 10:6, June 2004.
392
Orloff M, Bozorgzadeh A, AB Jain, Lansing K, Cullen J, Ryan C, Strang J. Impact of donor evaluation factors on post-operative liver function in adult-to-adult living liver donation: a retrospective multivariate analysis to establish donor safety criteria. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 114, Liver Transplantation 10:6, June 2004.
393
AB Jain, Orloff M, Kashyap R, Lansing K, Bozorgzadeh A. Use of Rapamycin in post-liver transplantation (LTX) for nephrotoxicity under calcineurin inhibitor. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 152, Liver Transplantation 10:6, June 2004.
394
AB Jain, Orloff M, Kashyap R, Menegus M, Mantry P, Ryan C, Romano J, Bryan L, Batzold P, Lansing K, Bozorgzadeh A. Safety and efficacy profile of pegylated interferon α2B (peg intron)® iv/s pegylated interferon α2A (Pegasys)® in post-liver transplant (LTx) hepatitis c virus (HCV) genotype 1A/1B patients. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 157, Liver Transplantation 10:6, June 2004.
395
Batzold P, AB Jain, Orloff M, Kashyap R, Milot P, Romano J, Bryan L, Cullen J, Lansing K, Burlee K, Merrick L, Vetter M, Sober C, Shisler T, Wrobble K, Bozorgzadeh A. Liver transplantation (LTX) for sarcoidosis: question of recurrence. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 158, Liver Transplantation 10:6, June 2004.
396
Bozorgzadeh A, AB Jain, Lansing K, Kashyap R, Orloff M. Impact of older donor grafts in liver transplant (LTx) recipients with hepatitis c viral (HCV) infection. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 161, Liver Transplantation 10:6, June 2004.
397
Bozorgzadeh A, AB Jain, Ryan C, Orndt D, Zand M, Mantry P, Lansing K, Orloff M. Living donor allograft versus cadaveric liver allograft for hepatitis c viral infection in 100 consecutive liver transplant recipients under tacrolimus: single center experience. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 162, Liver Transplantation 10:6, June 2004.
398
Bozorgzadeh A, AB Jain, Kashyap R, Lansing K, Orloff M. Survival outcome for hepatitis c recipients who received hepatitis b core antibody positive liver allograft. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 163, Liver Transplantation 10:6, June 2004.
399
Ashokkumar Jain, Sayeed Malek, Nikhil, Amesur, Randeep Kashyap, Amadeo Marcos, John Fung. The unknown, unusual anomaly of the splenic artery during abdominal multi-visceral organ procurement and intra-artery chemoembolization: case reports. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 188, Liver Transplantation 10:6, June 2004.
400
Zoran Vukcevic, Ashokkumar Jain. Pulmonary edema after liver transplantation as a sign of allograft failure and rejection. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 192, Liver Transplantation 10:6, June 2004.
401
AB Jain, Raman Venkataramanan, Bijan Eghtesad, Randeep Kashyap, Barbara Yelochan, Amadeo Marcos, and John Fung. Value of ribavirin concentration measurement in plasma /blood in post liver transplant patients with hepatitis C virus (HCV) infection. International Liver Transplant Society (ILTS) Annual Meeting, June 9-12, 2004, Kyoto, Japan. Abstract# 253, Liver Transplantation 10:6, June 2004.
402
Adel Bozorgzadeh. Ashok Jain, Kerrie Lansing, Randeep Kashyap, M. Orloff Impact of donor age in live donor liver transplantation for hepatitis C positive recipient. Poster presentation at 2nd International Conference entitled “Living Donor Abdominal Organ Transplantation: State of the Art” in Taormina, Sicily, Italy on June 25-27, 2004
403
Ashok Jain, M. Orloff, Randeep Kashyap, Adel Bozorgzadeh. Use of Intravenous (IV) Mycophenolate Mofetil (MMF) And Delayed Introduction of Dose Oral Tacrolimus to Preserve Renal Function in Living Donor Liver Transplantation. Poster presentation at 2nd International Conference titled “Living Donor Abdominal Organ Transplantation: State of the Art” in Taormina, Sicily, Italy on June 25-27, 2004
404
Adel Bozorgzadeh, Ashokkumar Jain, Charlotte Ryan, Daniel Orndt, Martin Zand, Parvez Mantry, Kerrie Lansing and Mark Orloff Living Donor Allograft Versus Cadaveric Liver Allograft for Hepatitis C Viral Infection In 100 Consecutive Liver Transplant Recipients Under Tacrolimus: Single Center Experience. Oral presentation at 2nd International Conference entitled “Living Donor Abdominal Organ Transplantation: State of the Art” in Taormina, Sicily, Italy on June 25-27, 2004
405
Jackie Cullen, Ashokkumar Jain, Mark Orloff, Randeep Kashyap, Kerrie Lansing, and Adel Bozorgzadeh Should Living Donor Liver Graft Be Considered for Retransplantation For Recurrent Hepatitis C. Poster presentation at 2nd International Conference entitled “Living Donor Abdominal Organ Transplantation: State of the Art” in Taormina, Sicily, Italy on June 25-27, 2004
406
J Cullen, A Jain, K Lansing, M Orloff, A Bozorgzadeh. Recurrence of Hepatocellular Carcinoma (HCC) In Live Donor Liver Transplantation Vs. Cadaveric Liver Transplantation To Staging Of the Disease Poster presentation at 2nd International Conference entitled “Living Donor Abdominal Organ Transplantation: State of the Art” in Taormina, Sicily, Italy on June 25-27, 2004
407
Bozorgzadeh A, Jain A, Kashyap R, Lansing K, Abt P, Orloff M. Impact of Older Donor Grafts in Liver Transplant (LTx) recipients with Hepatitis C viral (HCV) infection in 9th Congress of the Middle East Society of Organ Transplantation (MESOT) on December 6-10, Turkey
408
Bozorgzadeh A, Jain A, Kashyap R, Abt P, Lansing K, Orloff M. Survival outcome for hepatitis c recipients who received hepatitis B core antibody positive liver allograft. 9th Congress of the Middle East Society of Organ Transplantation (MESOT) on December 6-10, Turkey
409
Bozorgzadeh A, Jain A, Kashyap R, Lansing K, Abt P, Orloff M. Survival outcome after retransplantation for recurrent hepatitis C viral (HCV) infection. 9th Congress of the Middle East Society of Organ Transplantation (MESOT) on December 6-10, Turkey
410
Kelley M, Jain A, Orloff M, Kashyap R, Wrobble K, Venkataramanan R, Abt P, Bozorgzadeh A. Changes in oral absorption of tacrolimus in post liver transplant patients before and after reversal of Jejunoileal(j-i) bypass: case reports. 9th Congress of the Middle East Society of Organ Transplantation (MESOT) on December 6-10, Turkey
411
Jain A, Orloff M, Lansing K, Kashyap R, Kelley M, Betts R, Menegus M, Bozorgzadeh A. High rate of symptomatic cytomegaloviral (CMV) infection with valgan (ganciclovir hydrochloride) prophylaxis in post-liver transplant recipients. 9th Congress of the Middle East Society of Organ Transplantation (MESOT) on December 6-10, Turkey
412
Jain A, Venkataramanan R, Eghtesad B, Kashyap R, Yelochan B, Marcos A, Fung J. Value of ribavirin concentration measurement in plasma/blood in post liver transplant patients with hepatitis c virus (HCV) infection. 9th Congress of the Middle East Society of Organ Transplantation (MESOT) on December 6-10, Turkey
413
A Jain, M Giraldo, R Pokharna, J Fung, A Marcos Outcome of Liver Transplantation for Hemophiliacs and HCV, with or without HBV & HIV infection under Tacrolimus – Nine Years Experience from a single Centre Transplant Asia 2004, 1-4 December 2004, Singapore
414
Ashokkumar Jain, Mark Orloff, Randeep Kashyap, Kerrie Lansing, Roberts Betts, Marilyn Menegus, Charlotte Ryan, Peter Abt, Adel Bozorgzadeh Does Valganciclovir Hydrochloride (Valcyte TM) Provide Effective Prophylaxis against Cytomegalovirus (CMV) Infection in Liver Transplant Recipients? Transplant Asia 2004, 1-4 December 2004, Singapore
415
Ashok Jain, Renu Pokharna, Kareem Abu-Elmagd, Randeep Kashyap, Ron Shapiro, Velma Scantlebury, Bijan Eghtesad, Paulo Fontes, Mary Gadornski, Amadeo Marcos, John Fung Use of Rituximab (Chimeric Anti-CD20 Antibody) in Post Transplant Lymphoproliferative Disorder (PTLD) after Liver, Kidney and Pancreas Transplantation Transplant Asia 2004, 1-4 December, 2004, Singapore
416
Randeep Kashyap, Ashok Jain, Renu Pokharna, Kareem Abu-Elmagd, Ron Shapiro, Velma Scantlebury, Bijan Eghtesad, Paulo Fontes, Mary Gadornski, Amadeo Marcos, John Fung Impact of Cytomegalovirus (CMV) Hepatitis in Adult Post Transplant Allograft under Tacrolimus Transplant Asia 2004, 1-4 December 2004, Singapore
417
A Jain, M Orloff, R Kashyap, B Kari, A Bozorgzadeh. Use of Intravenous Mycophenolate Mofetil and delayed use of Tacrolimus in Deceased Donor Liver Transplantation to preserve Renal function, Transplant Asia 2004, 1-4 December 2004, Singapore
418
G Costa, Ashokkumar Jain, Amadeo Marcos, Jorge Reyes, George Mazariegos, R Kashyap, John J Fung Incidence of Bile Duct complications following Primary Liver Transplantation in Adults and Children: 1000 consecutive patients Transplant Asia 2004, 1-4 December 2004, Singapore
419
Ashokkumar B Jain, G Costa, Amadeo Marcos, Jorge Reyes, George Mazariegos, S Jorge Rakela, John J Fung Rate of Hepatic Artery Complications following Primary Liver Transplantation in Adults and Children: 1000 consecutive cases under Tacrolimus Transplant Asia 2004, 1-4 December 2004, Singapore
420
Ashokkumar Jain, Marilyn Menegus, Ravi Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzadeh. Preliminary result on hepatitis c viral (HCV) antibody titer to hepatitis c viral load, hepatic injury, and response to anti-HCV treatment in post-liver transplant (LTx) patients. American Association for the Study of Liver Diseases - Hepatitis Single Topic Conference “Hepatitis C Virus Infection: Pathobiology and Implications for New Therapeutic Options” 4-5 March 2005, Chicago, Illinois
421
Ashokkumar Jain, Mark Orloff, Peter Abt, Ravi Mohanka, Randeep Kashyap, Kerrie Lansing, Joan Romano, Adel Bozorgzadeh. Survival outcome after hepatic retransplantation for hepatitis C viral positive and negative recipients. American Association for the Study of Liver Diseases - Hepatitis Single Topic Conference “Hepatitis C Virus Infection: Pathobiology and Implications for New Therapeutic Options” 4-5 March 2005, Chicago, Illinois
422
Ashokkumar Jain, Mark Orloff, Peter Abt, Ravi Mohanka, Randeep Kashyap, Kerrie Lansing, Joan Romano, Adel Bozorgzadeh. Safety & efficacy of pegylated interferon alfa 2b vs. pegylated interferon alfa 2a in post-liver transplant (LTx) hepatitis C viral (HCV) genotype 1A/1B patients. American Association for the Study of Liver Diseases - Hepatitis Single Topic Conference “Hepatitis C Virus Infection: Pathobiology and Implications for New Therapeutic Options” 4-5 March 2005, Chicago, Illinois
423
Ashokkumar Jain, Raman Venkataramanan, Barbara Yelochan, Ravi Mohanka, Randeep Kashyap, Amadeo Marcos, John Fung. Ribavirin levels in post-liver transplant (LTx) patients treated for recurrent hepatitis c viral (HCV) infection. American Association for the Study of Liver Diseases - Hepatitis Single Topic Conference “Hepatitis C Virus Infection: Pathobiology and Implications for New Therapeutic Options” 4-5 March 2005, Chicago, Illinois
424
Adel Bozorgzadeh, Kerrie Lansing, Duraid Younan, Randeep Kashyap, Peter Abt, Ashokkumar Jain, Mark Orloff. Hepatitis C virus (HCV) infected Liver transplant (LTx) recipients with Hepatocellular carcinoma (HCC): survival outcome. American Association for the Study of Liver Diseases - Hepatitis Single Topic Conference “Hepatitis C Virus Infection: Pathobiology and Implications for New Therapeutic Options” 4-5 March 2005, Chicago, Illinois
425
Adel Bozorgzadeh, Peter Abt, Randeep Kashyap, Kerrie Lansing, Duraid Younan, Ashokkumar Jain, Mark Orloff. Hepatitis C virus (HCV) patients co-infected with cytomegalovirus (CMV) infection in post Liver transplant (LTx): impact on survival. American Association for the Study of Liver Diseases - Hepatitis Single Topic Conference “Hepatitis C Virus Infection: Pathobiology and Implications for New Therapeutic Options” 4-5 March 2005, Chicago, Illinois
426
Jain A, Eghtesad B, Broznck B, Kusum P, Sayeed M, Thomas C, De Vera ME, Fontes PA, Gayowski T, Marsh W, Marcos A, Fung J. University of Wisconsin (UW) versus Histidine-Tryptophan- Ketoglutarate (HTK) for tissue preservation in live donor liver transplantation. American Transplant Congress (ATC) May 21-25 2005, Seattle, WA
427
Bozorgzadeh A, Lansing K, Duraid Y, Kashyap R, Abt P, Jain A, Orloff M. Survival outcomes in hepatitis C (HCV) infected liver transplant (LTx) recipients with hepatocellular carcinoma (HCC). American Transplant Congress (ATC) May 21-25 2005, Seattle, WA
428
Lansing K, Jain A. (put other authors) Survival outcomes in hepatitis C (HCV) infected liver transplant (LTx) recipients with hepatocellular carcinoma (HCC). 11th International Liver Transplant Society (ILTS) Annual Meeting, July 20-23, 2005, Los Angeles, CA, USA.
429
Lansing K, Jain A. (put other authors) Risk factors and implications of vancomycin-resistant enterococcus (VRE) in liver transplant recipients. 11th International Liver Transplant Society (ILTS) Annual Meeting, July 20-23, 2005, Los Angeles, CA, USA.
430
Ashokkumar Jain, Marilyn Menegus, Ravi Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzadeh. Post liver transplant (LTx) hepatitis C viral (HCV) antibody titer to hepatitis C viral load, hepatic injury, and response to anti-HCV treatment – preliminary results. 11th International Liver Transplant Society (ILTS) Annual Meeting, July 20-23, 2005, Los Angeles, CA, USA.
431
Ashok Jain, Mark Orloff, Peter Abt, Ravi Mohanka, Randeep Kashyap, Jackie Cullen, Adel Bozorgzadeh. University of Wisconsin (UW) versus Histidine-Tryptophan-Ketoglutarate (HTK) for tissue preservation in live donor liver transplantation. 11th International Liver Transplant Society (ILTS) Annual Meeting, July 20-23, 2005, Los Angeles, CA, USA.
432
Ashok Jain, Mark Orloff, Peter Abt, Ravi Mohanka, Randeep Kashyap, Jackie Cullen, Adel Bozorgzadeh. Intra-operative biochemical changes in live donor liver transplantation at the end of parenchymal division. 11th International Liver Transplant Society (ILTS) Annual Meeting, July 20-23, 2005, Los Angeles, CA, USA.
433
A. Jain, M. Orloff, R Mohanka, R. Kashyap, M Kelley, K Burlee, A. Bozorgzadeh. Intravenous Mycophenolate Mofetil and delayed use of tacrolimus in deceased and live donor liver transplantation for preservation of renal function. 11th International Liver Transplant Society (ILTS) Annual Meeting, July 20-23, 2005, Los Angeles, CA, USA.
434
Cheryl Hokula, Ashokkumar B Jain, Mack Cindy, Julie Berkhof, Mary Johnson, Julie Burlee, Bianca Kotowski, Keri Kamali, Allen Erway, Robinson Renee, Wrobble Kristen, Shisler Tomi, Ravi R Mohanka, Randeep Kashyap, Mark Orloff, Peter Abt, and Adel Bozorgzadeh. Intravenous Mycophenolate Mofetil and delayed use of tacrolimus in deceased and live donor liver transplantation for preservation of renal function. 14th Annual ITNS Symposium and General Assembly. September 22- 24, 2005 • Orlando, Florida USA
435
Joan Romano, Ashokkumar B Jain, Linda Plano, Marilyn Menegus, Mack Cindy, Julie Berkhof, Mary Johnson, Julie Burlee, Allen Erway, Robinson Renee, Wrobble Kristen, Shisler Tomi, Ravi R Mohanka, Randeep Kashyap, Mark Orloff, Peter Abt, and Adel Bozorgzadeh. Post liver transplant (LTx) hepatitis c viral (HCV) antibody titer to hepatitis c viral load, hepatic injury, and response to anti- HCV treatment preliminary results. 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 • Orlando, Florida USA
436
Mary Gadomski, Ashokkumar Jain, Leah Kingrey, Kathy Nestler, Mary Beth Lewis, Amadeo Marcus. Tacrolimus for primary liver transplantation; 12 to 15 years actual follow-up with safety profile. 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 • Orlando, Florida USA
437
Mary Vetter, Ashokkumar B Jain, Pat Milot, Joan Romano, Leah Bryan, Pam Batzold, Linda Merrick, Mark Orloff, Peter Abt, Ravi R Mohanka, Randeep Kashyap, and Adel Bozorgzadeh. Intra- operative biochemical changes in live donor liver transplantation at the end of parenchymal division. 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 Orlando, Florida USA
438
Pat Milot, Ashokkumar B Jain, Jackie Cullen, Mary Vetter, Kerrie Lansing, Mark Orloff, Peter Abt, Ravi R Mohanka and Adel Bozorgzadeh. University of Wisconsin (UW) versus Histidine- Tryptophan-Ketoglutarate (HTK) for tissue preservation in live donor liver transplantation. 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 Orlando, Florida USA
439
Cynthia Mack, Adel Bozorgzadeh, Kerrie Lansing, Ashok Jain, Mark Orloff, Peter Abt. Outcome of late stage Hepatocellular carcinoma (HCC) in those outside of Milan / University of California, San Francisco (UCSF) criteria: results of a single center study. 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 Orlando, Florida USA
440
Cynthia Mack, Adel Bozorgzadeh, Kerrie Lansing, Ashok Jain, Mark Orloff, Peter Abt. Outcome of Hepatitis C patients co-infected with cytomegalovirus (CMV) post liver transplant (LTx). 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 Orlando, Florida USA
441
Adel Bozorgzadeh, Kerrie Lansing, Ashok Jain, Mark Orloff, Peter Abt. Survival & outcomes in Hepatitis C (HCV) infected liver transplant (LTx) recipients with hepatocellular carcinoma (HCC). 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 Orlando, Florida USA
442
Adel Bozorgzadeh, Kerrie Lansing, Ashok Jain, Mark Orloff, Peter Abt. Risk factors and implications of Vancomycin Resistant Enterococcus (VRE) in liver transplant recipients. 14th Annual ITNS Symposium and General Assembly. September 22-24, 2005 Orlando, Florida USA
443
Adel Bozorgzadeh, Kerrie Lansing, Duraid Younan, Randeep Kashyap, Peter Abt, Ashok Jain, Mark Orloff. Survival & Outcomes in Hepatitis C (HCV) infected liver transplant (LTx) recipients with hepatocellular carcinoma (HCC). 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
444
Duraid Younan, Randeep Kashyap, Peter Abt, Kerrie Lansing, Ashokkumar Jain, Parvez Mantry, Mark Orloff, Adel Bozorgzadeh. Hepatic artery stenosis in orthotopic liver transplantation (LTx): single center experience in a series of 527 patients. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
445
Ashokkumar B Jain, Mark Orloff, Peter Abt, Ravi R Mohanka, Randeep Kashyap, Adel Bozorgzadeh. University of Wisconsin (UW) versus Histidine-Tryptophan-Ketoglutarate (HTK) for tissue preservation in live donor liver transplantation. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
446
Peter Abt, Adel Bozorgzadeh, Duraid Younan, Randeep Kashyap, Kerrie Lansing, Ashok Jain, David Kauffman, Martin Zand, Mark Orloff. An association between healthcare utilization and outcomes in the MELD era. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
447
Adel Bozorgzadeh, Peter Abt, Randeep Kashyap, Ashokkumar Jain, Kerrie Lansing, Duraid Younan, Parvez Mantry, Mark Orloff. Optimal use of extended criteria organs in the MELD era. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
448
Adel Bozorgzadeh, Kerrie Lansing, Duraid Younan, Peter Abt, Randeep Kashyap, Robert Betts, Ashok Jain, Mark Orloff. Risk factors and implications of Vancomycin-resistant enterococcus (VRE) in liver transplant recipients. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
449
Ashokkumar B Jain, Marilyn Menegus, Ravi R Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzadeh, Post liver transplant (LTx) hepatitis C viral (HCV) antibody titer to hepatitis C viral load, hepatic injury and response to anti-HCV treatment – preliminary results. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
450
Adel Bozorgzadeh, Peter Abt, Randeep Kashyap, Kerrie Lansing, Duraid Younan, Ashokkumar Jain, Parvez Mantry, Mark Orloff. An association of pre-transplant HCV-associated cryoglobulinemia (CRG) with post-liver transplant survival outcomes. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
451
Adel Bozorgzadeh, Peter Abt, Randeep Kashyap, Kerrie Lansing, Duraid Younan, Ashokkumar Jain, Parvez Mantry, Mark Orloff. The outcome of hepatitis C patients co-infected with cytomegalovirus (CMV) infection post-liver transplant (LTx). 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
452
Randeep Kashyap, Duraid Younan, Kerrie Lansing, Peter Abt, Ashokkumar Jain, Mark Orloff, Adel Bozorgzadeh. Donor/Recipient cytomegalovirus (CMV) status and its influence on hepatic artery thrombosis (HAT) post-liver transplantation (LTx). 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
453
A B Jain, M Orloff, R Mohanka, R Kashyap, M Kelly, B Kari, P Abt, A Bozorgzadeh. Intravenous Mycophenolate Mofetil and delayed use of tacrolimus in deceased and live donor liver transplantation for preservation of renal function. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
454
Randeep Kashyap, Peter Abt, Duraid Younan, Kerrie Lansing, Ashokkumar Jain, Mark Orloff, Adel Bozorgzadeh. Liver transplantation from a non-heart-beating donor (NHBD) – a single-centre experience. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
455
Adel Bozorgzadeh, Peter Abt, Kerrie Lansing, Randeep Kashyap, Duraid Younan, Ashokkumar Jain, Parvez Mantry, Mark Orloff. Outcome of late stage hepatocellular carcinoma (HCC) those outside Milan / University of California, San Francisco (UCSF) criteria: results of a single center study. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA
456
Ashokkumar B Jain, Mark Orloff, Peter Abt, Ravi R Mohanka, Randeep Kashyap, Jackie Cullen, Adel Bozorgzadeh. Intra-operative biochemical changes in live donor liver transplantation at the end of parenchymal division. 11th Annual meeting of the International Liver Transplant Society (ILTS) July 21-24, 2005. Los Angeles, CA, USA.
457
Ashok Jain, Ravi Mohanka, Mark Orloff, Peter Abt, Randeep Kashyap, Parvez Mantry, Jackie Cullen, Kerrie Lansing, Adel Bozorgzadeh. Intraoperative biochemical changes in live donor liver transplantation at the end of parenchymal division and its post-operative impact. 12th Congress of the European Society for Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva, Switzerland
458
Ashok Jain, Mark Orloff, Ravi Mohanka, Randeep Kashyap, Mark Kelley, Kari Burlee, Adel Bozorgzadeh. Intravenous Mycophenolate Mofetil and delayed use of tacrolimus in deceased and live donor liver transplantation for preservation of renal function. 12th Congress of the European Society for Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva, Switzerland
459
Ashok Jain, Marilyn Menegus, Ravi Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzadeh. HCV antibody quantitative levels in post-liver transplant patients: do they have any relevance in clinical practice? 12th Congress of the European Society for Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva, Switzerland
460
Ashok Jain, Mark Orloff, Peter Abt, Ravi Mohanka, Randeep Kashyap, Jackie Cullen, Adel Bozorgzadeh. University of Wisconsin (UW) versus Histidine-Tryptophan-Ketoglutarate (HTK) for tissue preservation in live donor liver transplantation. 12th Congress of the European Society for Organ Transplantation (ESOT) 15th – 19th October 2005, Geneva, Switzerland
461
Ashok Jain, Charlotte Ryan, Ravi Mohanka, Mark Orloff, Peter Abt, Joan Romano, Leah Bryan, Pam Batzold, Adel Bozorgzadeh. Use of complement C4d stain to distinguish between acute cellular rejection and recurrent hepatitis C in post-liver transplant liver biopsy. 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). November 11 – 15, 2005. San Francisco, California, USA
462
Ashok Jain, Ravi Mohanka, Tai Kwong, Jamie Nelson, Cynthia Mack, Mark Orloff, Peter Abt, Adel Bozorgzadeh. Kinetics observation of IV Mycophenolate Mofetil (MMF) and oral MMF in live donor and diseased donor liver transplantation (LTx). 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). November 11 – 15, 2005. San Francisco, California, USA.
463
Mark Nickels, Ashokkumar Jain, Ravi Mohanka, Mark Orloff, Peter Abt, Adel Bozorgzadeh. Non-alcoholic Substance Abuse in Liver Transplant Patients and its Impact on Survival Outcome. 56th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). November 11 – 15, 2005. San Francisco, California, USA.
464
Bozorgzadeh A, Kashyap R, Abt P, Jain A, Younan D, Mohanka R, Maloo M, Orloff M. Donor risk index – can we prevent graft failure in liver transplantation? World Transplant Congress, Abstract #95 2006, Am J Transplant 2006, 6(Supp 2) and Transplantation 2006, 82(1) (Supp 3):98.
465
Kashyap R, Orloff M, Abt P, Jain A, Younan D, Maloo M, Mohanka R, Bozorgzadeh A. Rate of recurrence, retransplantation and survival outcomes after living donor liver transplantation for primary sclerosing cholangitis. World Transplant Congress, Abstract #324 2006, Am J Transplant 2006, 6(Supp 2) and Transplantation 2006, 82(1) (Supp 3):176.
466
Jain A, Mohanka R, Kwong T, Orloff M, Abt P, Mack C, Bozorgzadeh A. Pharmacokinetics of intravenous vs. oral Mycophenolate Mofetil (MMF) in live donor and deceased donor liver transplantation (LTx). World Transplant Congress, Abstract #494 2006, Am J Transplant 2006, 6(Supp 2) and Transplantation 2006, 82(1)(Supp 3):232.
467
Zand M, Demme R, Taylor J, Bozorgzadeh A, Abt P, Orloff M, Jain A, Irish-Feltner J. Living donor renal allograft size and function compared to the remaining native donor kidney: a prospective, randomized trial of sirolimus versus tacrolimus. World Transplant Congress, Abstract #756 2006, Am J Transplant 2006, 6(Supp 2) and Transplantation 2006, 82(1)(Supp 3):321.
468
Bozorgzadeh A, Kashyap R, Abt P, Jain A, Younan D, Maloo M, Mohanka R. Who benefits from ECD livers, the sick or stable patient? Utility of donor risk index. World Transplant Congress, Abstract #1004 2006, Am J Transplant 2006, 6(Supp 2) and Transplantation 2006, 82(1) (Supp 3):405.
469
Bozorgzadeh A, Kashyap R, Younan D, Jain A, Abt P, Mohanka R, Maloo M, Orloff M. Survival outcome post-liver transplant in recipients over 70 years of age. World Transplant Congress, Abstract #1420 Poster Board Session: P215-I 2006, Am J Transplant 2006, 6(Supp 2) and Transplantation 2006, 82(1) (Supp 3):544.
470
Kashyap R, Abt P, Orloff M, Jain A, Younan D, Mohanka R, Maloo M, Bozorgzadeh A. The utility of pre-operative magnetic resonance cholangio-pancrestography in right lobe liver living donor liver transplantation. World Transplant Congress, Abstract #1921 Poster Board Session: P248-II 2006, Am J Transplant 2006, 6(Supp 2) and Transplantation 2006, 82(1) (Supp 3):706.
471
Johnson R, Mantry P, Orloff M, Bozorgzadeh A, Mohanka R, and Jain A. Delayed onset duodenal perforation by a biliary stent after ERCP in a liver transplant recipient for anastomotic stricture of the common bile duct: case report. The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #27, Liver Transplantation, May 2006, 12(5):C-122.
472
Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, and Bozorgzadeh A. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post liver transplant biopsies. The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #28, Liver Transplantation, May 2006, 12(5):C-122.
473
Nickels M, Jain A, Mohanka R, Orloff M, Abt P, and Bozorgzadeh A. Non-alcoholic substance abuse in liver transplant patients and its impact on survival outcome. The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #29, Liver Transplantation, May 2006, 12(5):C-122.
474
Mohanka R, Jain A, Ryan C, Orloff M, Abt P, and Bozorgzadeh A. Histopathological patterns of PASD and A1A MAB Staining in ESLD due to A1A deficiency leading to liver transplant (LTx) in adults. The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #30, Liver Transplantation, May 2006, 12(5):C-122.
475
Mohanka R, Jain A, Orloff M, Abt P, Lansing K, Bozorgzadeh A, and Ryan C. Histopathological findings and survival outcome of living donor and deceased donor liver transplantation (LTx) with hepatitis C viral (HCV) genotype 3 infection. The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #33, Liver Transplantation, May 2006, 12(5):C-123.
476
Jain A, Mohanka R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Pharmacokinetics of oral tacrolimus in live donor (LDLT) and deceased donor (CAD) liver transplantation. The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #39, Liver Transplantation, May 2006, 12(5):C-125.
477
Jain A, Mohanka R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Rejection-free prospective immunosuppressive protocol for deceased donor and live donor liver transplantation without antibody induction. The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #40, Liver Transplantation, May 2006, 12(5):C-125.
478
Jain A, Mohanka R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Measurement of circulatory unhydrolyzed Mycophenolate Mofetil (MMF) to Mycophenolic Acid (MPA) with intravenous MMF in post-liver transplant patients. The 2006 Joint International Congress of 479. ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #41, Liver Transplantation, May 2006, 12(5):C- 125.
479
Jain A, Mohanka R, Kwong T, Orloff M, Abt P, and Bozorgzadeh A. Kinetics differences of IV and oral Mycophenolate Mofetil (MMF) in live donor and diseased donor liver transplantation (LTx). The 2006 Joint International Congress of ILTS, ELTA, & LICAGE, May 3-6 2006, Milan Marriott Hotel, Milan, Italy, LB #42, Liver Transplantation, May 2006, 12(5):C-125.
480
Norway K, Jain A, Erway A, Barrett J, Bacon D, Harvey B, MacDonald C, Olsen T, Himes M, Derleth M, Janes C, Errigo J, Mohanka R, Ryan C, Orloff M, Abt P, and Bozorgzadeh A. Use of complement C4d staining to distinguish between acute cellular rejection and recurrent hepatitis C in post-liver transplant liver biopsy. ITNS, October 5-7, 2006, Rotterdam, The Netherlands
481
Johnson M, Mohanka R, Jain A, Erway A, Berkhof J, Robinson R, Romano J, Orloff M, Abt P, and Bozorgzadeh A. Histological findings and survival outcomes of living donor and deceased donor liver transplantation (LTx) with hepatitis C viral (HCV) genotype 3 infection. ITNS, October 5-7, 2006, Rotterdam, The Netherlands
482
Gierlach J, Jain A, Erway A, Barrett J, Bacon D, Harvey B, MacDonald C, Olsen T, Mohanka R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Rejection-free prospective immunosuppressive protocol for deceased donor and live donor liver transplantation without antibody induction. ITNS, October 5-7, 2006, Rotterdam, The Netherlands
483
Johnson M, Mohanka R, Erway A, Berkhof J, Robinson R, Jain A, Orloff M, Abt P, and Bozorgzadeh A. Effect of liver transplant on pulmonary function in patients with Alpha 1 Antitrypsin (A1A) deficiency. ITNS, October 5-7, 2006, Rotterdam, The Netherlands
484
Gardner J, Jain A, Amorese H, Bonhotal H, Baker M, Dillenbach M, George K, Hainberger K, Iannone L, Kamali K , Lord-Walker A, Maron N, Palacio R, Pavik B, Rogers L, Sass M, Scalia A, Schuyler E, Vineyard T. Mohanka R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Kinetics observation of IV Mycophenolate Mofetil (MMF) and oral MMF in live donor and diseased donor live transplantation (LTx). ITNS, October 5-7, 2006, Rotterdam, The Netherlands
485
Kotowski B, Jain A, Lord-Walker A, Maron N, Palacio R, Pavik B, Rogers L, Sass M, Scalia A, Schuyler E, Vineyard T, Mohanka R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Pharmacokinetics of oral tacrolimus in live donor (LDLT) and deceased donor (CAD) liver transplantation. ITNS, October 5-7, 2006, Rotterdam, The Netherlands
486
Kotowski B, Jain A, Amorese H, Bonhotal H, Baker M, Dillenbach M, Gardner J, George K, Hainberger K, Iannone L, Kamali K, Mohanka R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Measurement of circulatory unhydrolyzed Mycophenolate Mofetil (MMF) to Mycophenolic Acid (MPA) with intravenous MMF in post-liver transplant patients. ITNS, October 5-7, 2006, Rotterdam, The Netherlands
487
Milot P, Nickels M, Jain A, Batzold P, Bryan L, Cullen J, Burlee K, Robinson R, Johnson M, Merrick-Grinnell L, Lansing K, Vetter M, Shisler T, Berkhof J, Mack C, Mohanka, R, Tai K, Orloff M, Abt P, and Bozorgzadeh A. Non-alcoholic substance abuse in liver transplant patients and its impact on survival outcome. ITNS, October 5-7, 2006, Rotterdam, The Netherlands
488
Bozorgzadeh A, Tsoulfas G, Kashyap R, Abt P, Safadjou S, Graham M, Maloo M, Jain A, Orloff M. Increasing Organ Usage: Large, Single-Center Experience with Extended Criteria Donors for Liver Transplantation, The American Society of Transplant Surgeons, 7 th Annual State of the Art Winter Symposium, January 12-14, 2007, Marco Island, Florida. Oral abstract presentation.
489
Tsoulfas G, Kashyap R, Horton P, Abt P, Safadjou S, Graham M, Maloo M, Jain A, Orloff M, Bozorgzadeh A. Using Livers from Hepatitis B Core Antibody Positive Donors Expands the Donor Pool without Adversely Affecting Survival, The American Society of Transplant Surgeons, 7 th Annual State of the Art Winter Symposium, January 12-14, 2007, Marco Island, Florida. Abstract #143.
490
Kashyap R, Tsoulfas G, Horton P, Abt P, Safadjou S, Graham M, Maloo M, Jain A, Orloff M, Bozorgzadeh A. Using Livers from Hepatitis C Positive Donors Does Not Adversely Impact on Patient Survival, The American Society of Transplant Surgeons, 7 th Annual State of the Art Winter Symposium, January 12-14, 2007, Marco Island, Florida. Abstract #145.
491
Patel SA, Abt PL, Tsoulfas G, Orloff MS, Kashyap, R, Jain A, Bozorgzadeh A. Living donor liver transplantation in the United States: identifying donors at risk for perioperative complications. American Transplant Congress May 5-9, 2007 Concurrent Session, Abstract #258.
492
Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Kashyap R, Mack C, Graham M, Safadjou S, Jain A, Zand MS. Dialysis post-liver transplant is associated with significantly decreased patient survival. American Transplant Congress May 5-9, 2007 Concurrent Session, Abstract #467.
493
Jain A, Ryan C, Orloff M, Abt P, Tsoulfas G, Kashyap R, Milot P, Bozorgzadeh A. Comparison between H & E stain vs. Gomori Trichrome stain to estimate fibrosis score in post liver transplant allograft in hepatitis C positive patients. American Transplant Congress May 5-9, 2007 Poster Session, Abstract #875.
494
Tsoulfas G, Orloff M, Kashyap R, Abt P, Jain AB, Safadjou S, Graham M, Horton P, Maloo M, Bozorgzadeh A. Biliary reconstruction in right lobe living donor liver transplantation: comparison of different techniques. American Transplant Congress May 5-9, 2007 Poster Session, Abstract #892.
495
Orloff M, Tsoulfas G, Kashyap R, Abt P, Graham M, Safadjou S, Maloo M, Horton P, Jain A, Bozorgzadeh A. Liver grafts from donors with CNS tumors: a single center perspective. American Transplant Congress May 5-9, 2007 Poster Session, Abstract #893.
496
Kashyap R, Abt P, Tsoulfas G, Maloo M, Horton P, Safadjou S, Graham M, Jain A, Orloff M, Bozorgzadeh A. Preoperative magnetic resonance cholangio pancreatography (MRCP) imaging allows to stratify risk of biliary complications in right lobe living donor liver transplantation (LDLT). American Transplant Congress May 5-9, 2007 Poster Session, Abstract #908. 06/20/2007 - 06/23/2007
497
Bozorgzadeh A, Tsoulfas G, Kashyap R, Abt P, Horton P, Maloo M, Safadjou S, Graham M, Jain A, Orloff M. Increasing organ use: large, single-center experience with extended criteria donors for liver transplantation, ILTS 13th Annual Congress, June 20th-23rd, 2007, Rio de Janeiro, Brazil, Poster Board Session: P40-II, Liver Transplantation 13(6)supp 1:S1306/20/2007 - 06/23/2007
498
Jain A, Ryan C, Orloff M, Abt P, Milot P, Bozorgzadeh A. Should fibrosis score in post-liver transplant allograft for hepatitis C recurrence be always estimated with gomori trichrome stain? ILTS 13th Annual Congress, June 20th-23rd, 2007, Rio de Janeiro, Brazil, Poster Board Session: P119-I, Liver Transplantation 13(6)supp 1:S96 06/20/2007 - 06/23/2007
499
Jain A, Venkataramanan R, Orloff M, Abt P, Bozorgzadeh A. Pharmacokinetics of tacrolimus in live donor liver transplantation (LDLT) vs. deceased donor liver transplantation (DDLT), ILTS 13th Annual Congress, June 20th-23rd, 2007, Rio de Janeiro, Brazil, Abstract #176, Liver Transplantation 13(6) supp 1:S112 06/20/2007 - 06/23/2007
500
Kashyap R, Abt P, Tsoulfas G, Maloo M, Horton P, Safadjou S, Graham M, Jain A, Orloff M, Bozorgzadeh A. Preoperative magnetic resonance cholangiopancreatography (MCRP) imaging allows to stratify risk of biliary complications in right lobe living donor transplantation (LDLT), ILTS 13th Annual Congress, June 20th-23rd, 2007, Rio de Janeiro, Brazil, Abstract #429, Liver Transplantation 13(6) Supp 1: S186 06/20/2007 - 06/23/2007
501
Kashyap R, Tsoulfas G, Horton P, Orloff M, Abt P, Maloo M, Graham M, Safadjou S, Jain A, Bozorgzadeh A. Using livers from hepatitis-C positive donors does not adversely affect survival, ILTS 13th Annua06/20/2007 - 06/23/2007
502
Tsoulfas G, Kashyap R, Abt P, Jain A, Horton P, Maloo M, Safadjou S, Graham M, Orloff M, Bozorgzadeh A. Liver transplantation for incidental cholangiocarcinoma: large single center experience, ILTS 13th Annual Congress, June 20th-23rd, 2007, Rio de Janeiro, Brazil, Abstract #448, Liver Transplantation 13(6) Supp 1: S191 06/20/2007 - 06/23/2007
503
Tsoulfas G, Kashyap R, Abt P, Orloff M, Horton P, Maloo M, Safadjou S, Graham M, Jain A, Bozorgzadeh A. Using livers from hepatitis B core antibody-positive donors expands the donor pool without adversely affecting survival, ILTS 13th Annual Congress, June 20th-23rd, 2007, Rio de Janeiro, Brazil, Poster Board Session: P39-I, Liver Transplantation 13(6) Supp 1: S73 06/20/2007 - 06/23/2007
504
Tsoulfas G, Orloff M, Kashyap R, Abt P, Jain A, Safadjou S, Graham M, Horton P, Maloo M, Bozorgzadeh A. Biliary reconstruction in right lobe living-donor liver transplantation: comparison of different techniques, ILTS 13th Annual Congress, June 20th-23rd, 2007, Rio de Janeiro, Brazil, Poster Board Session: P18-II, Liver Transplantation 13(6) supp 1:S125 l 1
505
Jain A, Venkataramanan R, Kwong T, Orloff, M, Abt P, Kashyap R, Tsoulfas G, Mack C, Batzold P, Williamson M, Bozorgzadeh A. Pharmacokinetics of Tacrolimus and Mycophenolate Mofetil (MMF) in Live Donor and Deceased Donor Liver Transplant Recipients, European Association for the Study of the Liver 42 nd Annual Meeting, Barcelona Spain April 11-15, 2007. Abstract.
506
Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P, Kashyap R, Tsoulfas G, Batzold P, Williamson M, Bozorgzadeh A. Pharmacokinetics of Tacrolimus in Live Donor Liver Transplant (LDLT) and Deceased Donor Liver Transplant (DDLT) Recipients, Transplant Immunosuppression 2007: The Ongoing Search for Improvement, Minneapolis, Minnesota October 17- 20, 2007. Abstract.
507
Jain A, Venkataramanan R, Kwong T, Mohanka R, Orloff, M, Abt P, Kashyap R, Tsoulfas G, Sharma R, Mack C, Batzold P, Bozorgzadeh A. Pharmacokinetics of Mycophenolic Acid in Liver Transplant Patients after Intravenous and Oral Administration of Mycophenolate Mofetil (MMF), Transplant Immunosuppression 2007: The Ongoing Search for Improvement, Minneapolis, Minnesota October 17-20, 2007. Abstract.
508
Jain A, Sharma R, Ryan C, Tsoulfas G, Orloff M, Abt P, Kashyap R, Batzold P, Sauberman L, Safadjou S, Graham M, Bozorgzadeh A. Immunological advantage of intravenous Mycophenolate Mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction, Transplant Immunosuppression 2007: The Ongoing Search for Improvement, Minneapolis, Minnesota October 17-20, 2007. Abstract.
509
Patel S, Lent I, Bozorgzadeh A, Orloff M, Tsoulfas G, Kashyap R, Jain A, Abt P. Graft survival after living donor or cadaveric liver transplantation: an analysis stratified by donor risk. AASLD November 2-6 Boston, MA, Abstract, Hepatology 45(4) Suppl, page 484A, October 2007
510
Parvez Mantry, Randeep Kashyap, Saman Safadjou, Georgios Tsoulfas, Ashok Jain, Mark Orloff, Benedict Maliakkal, Adel Bozorgzadeh. Long-Term Outcome of Re-Liver Transplantation for Diseases Other Than Recurrent Hepatitis C – Impact of the MELD Score. American Transplant Congress May 31-June 3, 2008. American J Transplant May 2008; 8(s2): 380. Abstract # 754
511
Parvez Mantry, Randeep Kashyap, Saman Safadjou, Georgios Tsoulfas, Ashok Jain, Mark Orloff, Benedict Maliakkal, Adel Bozorgzadeh. Differentiating Recurrent HCV Infection from Other Causes of Graft Loss Has a Significant Impact on Outcome of Re-Transplantation: A Single Center Experience. American Transplant Congress May 31-June 3, 2008. American J Transplant May 2008; 8(s2): 609. Abstract # 1623
512
Ashok Jain, Rajeev Sharma, Charlotte Ryan, Saman Safadjou, Mark Orloff, Randeep Kashyap, Georgios Tsoulfas, Adel Bozorgzadeh. Response to Pegylated Interferon and Ribavirin Therapy in Live donor Liver Transplantation for Recurrent Hepatitis C Viral Infection. 14th Annual International Congress, July 9-12, 2008, Paris, France. Liver Transplantation 2008: 14(S1): S90. Abstract # 83
513
Ashok Jain, Rajeev Sharma, Charlotte Ryan, Georgios Tsoulfas, Mark Orloff, Randeep Kashyap, Adel Bozorgzadeh. Acute Cellular Rejection with Hepatitis C viral Infection in Liver Transplant Recipients when to treat and when not to treat, An Algorithmic approach: Asingle Center Experience. 14th Annual International Congress, July 9-12, 2008, Paris, France. Liver Transplantation 2008: 14(S1): S180. Abstract # 404
514
Ashok Jain, Rajeev Sharma, Saman Safadjou, Charlotte Ryan, Mark Orloff, Randeep Kashyap, Georgios Tsoulfas, Maureen Graham, Parvez Mantry, Benedict Maliakkal, Adel Bozorgzadeh. Response to Anti-Hepatitis C viral (HCV) Therapy in Post-liver Transplant Patients with Recurrent HCV Hepatitis: A Single Center Experience. 14th Annual International Congress, July 9-12, 2008, Paris, France. Liver Transplantation 2008: 14(S1): S180-181. Abstract # 406
515
Mark Nickels, Ashok Jain, Rajeev Sharma, Mark Orloff, Randeep Kashyap, Georgios Tsoulfas, Adel Bozorgzadeh. Polysubstance abuse in Liver Transplant patients and its impact on Survival Outcome. 14th Annual International Congress, July 9-12, 2008, Paris, France. Liver Transplantation 2008: 14(S1): S248. Abstract # 631
516
Nicole M. Sifontis, Edward Yung, David Spurrier, Ashok Kumar Jain, Serban Constantinescu, Iris Lee, Ellen Daly, Dawn Maiorano, Patricio Silva, Andreas Karachristos, John A. Daller. 3 Year Outcomes of Renal Transplantation in High-Risk Obese Recipients. American Transplant Congress May 30-June 2, 2009. American J Transplant May 2009; 9(s2): 515. Abstract # 1152
517
Nicole M. Sifontis, Argenis Herrera, Serban Constantinescu, Ellen Daly, Iris Lee, Ashok Kumar Jain, Andreas Karachristos, Patricio Silva, John A. Daller, Christopher Coombs. Prior Substance Abuse Does Not Affect Graft Survival or Patient Mortality in Renal Transplant Recipients. American Transplant Congress May 30-June 2, 2009. American J Transplant May 2009; 9(s2): 517. Abstract # 1157
518
Ashok K. Jain, Omer Faiz, Rajeev Sharma, Saman Safadjou, Randeep Kashyap, Baber Y. Sheikh, Leah Bryan, Pam Batzold, Mark Orloff. Recurrence of Non-Hepatic Malignancy Following Liver Transplantation (LTx) Guideline in Recurrence Free Survival Pre-LTx. American Transplant Congress May 30-June 2, 2009. American J Transplant May 2009; 9(s2): 529. Abstract # 1202
519
Ashokkumar Jain, Vrishali Patil, Charlotte Ryan, Rajeev Sharma, Saman Safadjou, Baber Sheikh, Randeep Kashyap, Mark Orloff. Guideline To Treat Acute Cellular Rejection in Presence of Hepatitis C Viral (HCV) Infection in Post Liver Transplant Recipients to Hepatitis Activity Index. Single Centre Experience. American Transplant Congress May 30-June 2, 2009. American J Transplant May 2009; 9(s2): 688. Abstract # 1804
520
Ashokkumar Jain, Vrishali Patil, Charlotte Ryan, Rajeev Sharma, Saman Safadjou, Baber Sheikh, Randeep Kashyap, Mark Orloff. Proposal To Treat Acute Cellular Rejection in Presence of Hepatitis C Viral (HCV) Infection in Post Liver Transplant Recipients to Hepatitis Activity Index (HAI). Single Centre Experience. 15th Annual International Congress, July 8-11, 2009, New York, USA. Liver Transplantation 2009: 15(S7): S76. Abstract # O-18
521
Ashok K. Jain, Omer Faiz, Rajeev Sharma, Saman Safadjou, Baber Y. Sheikh, Leah Bryan, Pam Batzold, Randeep Kashyap, Mark Orloff. Liver Transplant (LTx) in Patient with History of Non-Hepatic Malignancy. 15th Annual International Congress, July 8-11, 2009, New York, USA. Liver Transplantation 2009: 15(S7): S142. Abstract # P-80
522
Ashokkumar B. Jain, Vishali Patel, Michaele Apostolakos, Baber Sheikh, Randeep Kashyap, Mark Orloff. Effect of Liver Transplant on Pulmonary Functions in Adult Patients with Alpha 1 Antitrypsin (A1A) Deficiency. 15th Annual International Congress, July 8-11, 2009, New York, USA. Liver Transplantation 2009: 15(S7): S153-154. Abstract # P-115
523
Ashokkumar Jain, Pauline Nemitz, Rajeev Sharma, Marry Vetter, Leah Brayan, Baber Sheikh, Pam Batzold, Randeep Kashyap, Mark Orloff. Abdominal Cutaneous Numbness in the Supraumblical Region Post Liver Transplant (LTx) patient and its complications. 15th Annual International Congress, July 8-11, 2009, New York, USA. Liver Transplantation 2009: 15(S7): S170. Abstract # P-173
524
Rajeev Sharma, Randeep Kashyap, Ashok Jain Saman Safadjou, Mark Orloff. Comparison of Morbidity following Liver Transplantation in patients with and without Portal vein Thrombosis- A Single Center Experience. 15th Annual International Congress, July 8-11, 2009, New York, USA. Liver Transplantation 2009: 15(S7): S272. Abstract # P-519
525
Ashokkumar B. Jain, Baber Y. Sheikh, Saman Safadjou, Randeep Kashyap, Mark Orloff. Long Term Follow-Up of the Impact of Hepatitis C Viral Infection in Primary Living Donor Allograft Versus Primary Deceased Liver Allograft in 100 Consecutive Liver Transplant Patients on Tacrolimus. 16th Annual International Congress, June 16-19, 2010, HongKong, China. Liver Transplantation 2010: 16(S1): S88-89. Abstract # O-66
526
Aaditya Singhal, Andreas Karakristos, Benjamin Sanchez, Florin Deger, Ashokkumar B. Jain. Evaluation of Dobutamine Stress Echocardiography in Patients with Liver Failure. 16th Annual International Congress, June 16-19, 2010, HongKong, China. Liver Transplantation 2010: 16(S1): S218. Abstract # P-351
527
Ashokkumar Jain, Paulo Fontes, George Mazariegos, Michael DeVera, Kyle Soltys, Thomas Cacciarelli, Roberto Lopez, Rakesh Sindhi, Abhinav Goyal, Abhinav Humar, Wallis J. Marsh.1000 Consecutive Primary Liver Transplants: Actual 17 to 20 Year Longitudinal Follow-Up. 16th Annual International Congress, June 16-19, 2010, HongKong, China. Liver Transplantation 2010: 16(S1): S244-
528
Ashish Singhal, Andreas Karachristos, Benjamin Sanchez, Ashokkumar Jain. Chronotropic Incompetence on Dobutamine Stress Echocardiography in Candidates for Liver Transplantation. Am J Transpl 2011; 11(s2): 330, P # 1017.
529
Jacqueline M vonVital, Andreas Karachristos, Ashish Singhal, Rebecca Thomas, Ashokkumar Jain. Acute Amiodarone Hepatotoxicity following Liver Transplantation. Liver Transplantation 2011; 17(s1): s248, P # 403.
530
Ellen Daly, Ashish Singhal, Andreas Karachristos, Elaine Lander, Phyllis Dowling, Ashokkumar Jain. ABO compatible but Nonidentical Adult Liver Transplantation in patients with High MELD score. Liver Transplantation 2011; 17(s1): s288, P # 542.
531
Elaine Lander, Ashish Singhal, Andreas Karachristos, Ellen Daly, Phyllis Dowling, AshokKumar Jain. Elevation of CA 19-9 and CA 125 in Patients with End Stage Liver Disease. Liver Transplantation 2011; 17(s1): s219, P # 300.
532
AshokKumar Jain, Ashish Singhal, Serban Constantinescu, Avrum Gillespie, Adeel Masood, Andreas Karachristos. Intravenous Mycophenolate mofetil with Calcineurin Inhibitor for Renal Preservation following Liver Transplantation. Liver Transplantation 2011; 17(s1): s209, P # 264.
533
Ashish Singhal, Adeel Masood, Andreas Karachristos, Elaine Lander, Ellen Daly, Phyllis Dowling, AshokKumar Jain. Prevalence of Hypercoagulation and its association with Portal Vein Thrombosis (PVT) in Patients with End-Stage Liver Disease (ESLD). Liver Transplantation 2011; 17(s1): s141, P # 30.
534
Andreas Karachristos, Ashish Singhal, Adeel Masood, Benjamin Powers, AshokKumar Jain. A Modified Bilateral Subcostal Incision Reduces the Incidence of Abdominal Wall Complications in Liver Transplantation. Liver Transplantation 2011; 17(s1): s242, P # 383.
535
Ashish Singhal, Hinel Patel, Andreas Karachristos, Adeel Masood, AshokKumar Jain. Does Outcome of Liver Transplants from Older Donors with or without Recovery of Thoracic Organs is different? Liver Transplantation 2011; 17(s1): s144-s145, P # 43
536
Phyllis Dowling, Jacqueline M. von Vital, Andreas Karachristos, Ashish Singhal, Ellen Daly, Elaine Lander, Rebecca Thomas, Ashokkumar Jain. Acute Amiodarone Hepatotoxicity following Liver Transplantation. ITNS 20th Annual Symposium and General Assembly, September 15-17, 2011, Goteborg, Sweden.
537
Ellen Daly, Ashish Singhal, Andreas Karachristos, Elaine Lander, Phyllis Dowling, Ashokkumar Jain. ABO Compatible But Non-Identical Adult Liver Transplantation. ITNS 20th Annual Symposium and General Assembly, September 15-17, 2011, Goteborg, Sweden
538
Elaine Lander, Ashish Singhal, Andreas Karachristos, Ellen Daly, Phyllis Dowling, AshokKumar Jain. Elevation of CA 19-9 and CA 125 in Patients with End Stage Liver Disease. ITNS 20th Annual Symposium and General Assembly, September 15-17, 2011, Goteborg, Sweden.
539
Phyllis Dowling, Ashish Singhal, Serban Constantinescu, Avrum Gillespie, Elaine Lander, Ellen Daly, Andreas Karachristos, Ashokkumar Jain. Intravenous (IV) Mycophenolate mofetil (MMF) with Calcineurin Inhibitor (CNI) for Renal Preservation following Liver Transplantation. ITNS 20th Annual Symposium and General Assembly, September 15-17, 2011, Goteborg, Sweden
540
Ellen Daly, Ashish Singhal, Andreas Karachristos, Elaine Lander, Phyllis Dowling, AshokKumar Jain. Hypercoagulation and its association with Portal vein thrombosis in Patients with End-stage Liver Disease. ITNS 20th Annual Symposium and General Assembly, September 15-17, 2011, Goteborg, Sweden
541
Elaine Lander, Ashish Singhal, Andreas Karachristos, Ellen Daly, Phyllis Dowling, AshokKumar Jain. A Modified Bilateral Subcostal Incision Reduces the Incidence of Abdominal Wall Complications in Liver Transplantation. ITNS 20th Annual Symposium and General Assembly, September 15-17, 2011, Goteborg, Sweden
542
Elaine Lander, Ashish Singhal, Andreas Karachristos, Ellen Daly, Phyllis Dowling, Nicole Sifontis, Heather Clauss, AshokKumar Jain. Early Cytomegalovirus (CMV) Viremia Following Liver Transplantation: Case Report. ITNS 20th Annual Symposium and General Assembly, September 15-17, 2011, Goteborg, Sweden.
543
Ashish Singhal, Andreas Karachristos, Benjamin Sanchez, Ashokkumar Jain. Chronotropic Incompetence on Dobutamine Stress Echocardiography in Candidates for Liver Transplantation. ESOT 2011, September 4-7, 2011, Glasgow, UK. Abtract# O-097.
544
AshokKumar Jain, Ashish Singhal, Serban Constantinescu, Avrum Gillespie, Andreas Karachristos. Intravenous Mycophenolate mofetil with Calcineurin Inhibitor for Renal Preservation following Liver Transplantation. ESOT 2011, September 4-7, 2011, Glasgow, UK. Abstract# RO-325.
545
Ashokkumar Jain, Manoj Maloo, Andreas Karachristos, Phyllis Dowling, Gordon Nicholson, Vishal Patel, Elaine Lander. Quality Assessment and Performance Improvement (QAPI) with Increased Regulatory Compliance and Improved Patient Management in all Phases of Liver Transplantation. ILTS 2012, May 16 th -19 th , 2012, San Francisco, USA.
546
Ashokkumar Jain, Khushbu Majmundar, Yanhua Li, Manoj Maloo, Andreas Karachristos, Vishal Patel, Elain Lander. Thrombocytopenia with End-Stage Liver Disease and Improvement after Liver Transplantation. ILTS 2012, May 16 th -19 th , 2012, San Francisco, USA.
547
Ashokkumar Jain, Manoj Maloo, Andreas Karachristos, Gordon Nicholson, Vishal Patel, Phyllis Dowling. Utility of Quantitative Measurements of Marijuana Metabolites in Urine to Monitor Abstinence from use of Marijuana during Liver Transplant Evaluation. ILTS 2012, May 16 th -19 th , 2012, San Francisco, USA.
548
Ashokkumar Jain, Manoj Maloo, Andreas Karachristos, Vishal Patel How to Keep Patients Tranplantable with End-Stage Liver Disease and High MELD Scores. ILTS 2012, May 16 th -19 th , 2012, San Francisco, USA.
549
Jain, A., Mukerji, A. (2012, August). Current Global Status of Liver Transplantation: Rejection Free Immunosuppressive Protocol without Antibody Induction. Oral Presentation presented at First China Lanzhou International Summit Forum on Minimally Invasive Surgery; Lanzhou, China. of HLA Selected Platelet Transfusion in Highly Sensitized Liver Transplant Recipients 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract #P-25, pp. S44
551
Lander E, Jain A, Mukerji A, Karachristos A, Patel V, Daly E, Dowling P, Macdonald, B How to keep patients transplantable with end-stage liver disease and high MELD scores until we find them an organ. Twenty-first annual ITNS symposium and General Assembly at Seattle 2012
552
Macdonald, B. Jain, A. Lander E, Mukerji A, Karachristos A, Patel V, Daly E, Dowling P, Gordon Nicolson.Utility of serial Quantitative Measurements of Marijuana Metabolites in Urine to Monitor Abstinence from use of Marijuana during Liver Transplant Evaluation Twenty-first annual ITNS symposium and General Assembly at Seattle -2012
553
Dowling P, MacDonald B, Nicolson G, Lander E, Daly E, Jain A. Quality assessment and performance improvement (QAPI) with increased regulatory compliance and improved patient management in all phases of liver transplantation: How we do it? Twenty-first annual ITNS symposium and General Assembly at Seattle 2012
554
Lander E, Jain A, Mukerji A, Karachristos A, Patel V, Daly E, Dowling P, Macdonald, thrombocytopenia with End-Stage Liver Disease and Improvement after Liver Transplantation. Twenty- first annual ITNS symposium and General Assembly at Seattle 2012 How Long Introduction of Tacrolimus Can Be Delayed to Preserve the Nephron and Prevent Acute Rejection after Liver Transplantation (LTX) Using Intravenous (IV) Mycophenolate Mofetil (MMF) without Use of Antibody?19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract #P-56, pp. S46
556
Vishal Patel, Amar Mukerji, Andreas Karachristos, Manoj Maloo, Ashokkumar Jain, Post-LiverTransplant (LTx) in HBV DNA Positive Recipients: A Case Report? 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract # P-121 pp. S50 Leucopenia: Mycophenolate Mofetil and Allopurinol Drug Interaction in Liver Transplant Recipient? A Case Report. 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract # P-220 pp. S57 Liver Transplant Patients Need Thromb-Prophylactic Anticoagulation? 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract # P-382 pp. S67
559
V. Patel, J. Chapokas, A. N. Mukerji, M. Black, E. Daly, A. Karachristos, M. Maloo, A. Jain, Transplant: Case Reports. 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract # LB-23 pp. S69
560
Elaine Lander, Amar N. Mukerji, Selwyn Rogers, Gordon Nicholson, Angela Miller, Andreas Influence of Ethnicity and Other Factors on Time from Evaluation to Wait-Listing for Liver Transplantation. 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract #LB-23 Page S69
561
Amar N. Mukerji, Andrea Karachristos, Manoj Maloo, David Johnson, Elaine Lander, Vishal Patel, Concentration (WBTC) after Discontinuation of Prolonged Use of Fluconazole in Liver Transplant Recipients. 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract #LB-28 Page S81
562
Amar N. Mukerji, Steven Geier, Hermant Parekh, Raghava Potula, Andreas Karachristos, Manoj Transplantation (LT): A Pilot Study. 19 Meeting of International Liver Transplantation Society (ILTS). June 12 – June 15, 2013, Sydney, Australia, Liver Transplantation, June 2013 Vol. 19 No 6., Abstract # LB-29 Page S82
563
A Jain, A Mukerji, A. Karachristos, M. Maloo, K. Lau, A. Di Carlo Role of Intravenous (IV) Mycophenolate Mofetil (MMF) with delayed introduction of tacrolimus in liver transplant (LTx) recipients who have severe renal dysfunction at the time of transplant. The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014 London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6., Abstract #P-, pp. S
564
N. Brister, M. Kerestury, D Johnson, A. Karachristos, M. Maloo, K. Lau, A. Di Carlo A. Jain, MD1. Use of recombinant activated factor VII (rFVIIa) during liver transplantation (LTx) for primary dysfunction or delayed function of hepatic Allograft The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014 London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6., Abstract #P-, pp. S
565
A. Jain, A. Pathak, Johnson, A. Karachristos, M. Maloo, K. Lau, A. Di Carlo Use of continuous intravenous Bumetanide infusion with Albumin for oliguria with functioning hepatic allograft after liver transplantation (LTx). The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014 London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6., Abstract #P-, pp. S
566
S Geier, A Mukerji, H Parehkh, P Lai, A arachristos, M Maloo, and A. Jain, Liver Transplantation Monitoring of Serum Cytokines as Biomarkers for overall Immunosuppression. The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014 London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6., Abstract #P-, pp. S
567
M Maloo, H Clauss, A Karachristos, K Lau, A Di Carlo, and A Jain, 1Hip Joint Pain: A rare initial presentation of cryptococcal osteomyelitis and septic arthritis after LiverTransplantation. The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014 London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6., Abstract #P-, pp. S
568
A Jain, A Murkerji, A Karachristos, M. Maloo, K. Lau and A. Di Carlo, Role of Intravenous (IV) Mycophenolate Mofetil with delayed introduction of tacrolimus in liver transplant (LTx) recipient who is on renal replacement therapy (RRT) prior to LTx. The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014, London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6, Abstract #P- pp. S
569
H. Parekh, A Mukerji, S. Geier, A. Jain, Role of soluble CD30 (sCD30) levels to monitor overall immunosuppression after liver transplantation (LTx). The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014 London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6., Abstract #P- pp. S
570
A Mukerji, R Potula, S Geier, H Parekh, PHD3, A. Karachrstos, M. Maloo MD1, and A Jain, MD1Immunological biomarker for overall immunosuppression (IS) in liver transplant (LTx) recipients usingproliferation index of CD4 & CD8 lymphocytes stimulated with monoclonal anti-CD3 & anti- CD28 antibodies. The 2014 Joint International Congress of ILTS, ELITA & LICAGE London June 2014 London UK June 2014 Liver Transplantation, June 2014 Vol. 20 No 6., Abstract #P- pp. S
571
E. Lander, E. Daley, P. Dowling, A. Miller, G. Nicholson E. Trouse. A. Jain. Ethnicity differences from evaluation of successful listing for liver transplantation 23 rd Annual ITNS Symposium 2014, Sept 27-29. Houston USA
572
E. Daley, P. Dowling, E. Lander, E. Trouse. A. Jain. Use of HLA-selected platelets transfusion liver transplant recipients with severe thrombocytopenia from HLA antibodies.23 rd Annual ITNS Symposium2014 Sept 27-29. Houston USA
573
E. Lander, E. Daley, P. Dowling, A. Miller, G. Nicholson, E. Trouse. A. Jain. Intravenous Mycophenolate Mophetil and Progressive Delayed Introduction of Tacrolimus after liver transplantation to preserve renal function and reduce rejection.23 rd Annual ITNS Symposium 2014, Sept 27-29. Houston USA
574
P. Dowling, H. Clauss, E. Lande, E. Daley, M. Maloo. A. Jain. Septic arthritis of hip from Cryptococcal infection –An initial presentation after liver transplantation 23 rd Annual ITNS Symposium 2014, Sept 27-29. Houston USA
575
Steroid Free Immunosuppression Protocol in Pediatric Kidney Transplant Recipients Using Riaz Ali Shah, MD, Zakiyah Kadry, MD, Steven Wassner, MD, Deborah Kees-Folts, MD, Michael Freeman, MD, Peter Freeman, RN, BS, MPA, Brooke Olenowski, MPA and Ashokkumar Jain, MD.
576
Habig DF, Gaspari JL, Lokhandwala PM, Domen RE, Abendroth CS, Zakiyah Kadry Z, Ghahramani N, Shah RA, Jain A, Shike H, Donor-specific antibody to trans-encoded donor HLA-DQ heterodimer. Human Immunology 2015;76(8):587-90. Poster Presentation
577
Tyler JL, Gaspari JL, Mowery CL, Fisher CL, Kadry Z, Gharamani N, Shah RA, Jain A, Domen RE, Shike H. DSA and C1q assay in kidney post-transplant monitoring. American Society of Histocompatibility and Immunogenetics (ASHI) 41 st Annual Meeting, Savannah, GA. Sept 29-Oct 2, 2015. Poster #P017
578
Jain A, Kadry Z, Buchman S, Shah RA, Riley T, Dye C, Krok K, Moyer M, Schreibman I, Mathew A. Utility of ERCP stent placement for choledocho-choledochostomy during Liver Transplantation; Lessons Learned. International Liver Transplant Society, Seoul, Korea. May 4-7, 2016. Poster Presentation.
579
Krok K, Riley T, Schreibman I, Kadry Z, Jain A, Shah RA. Histologic Changes Consistent with Hepatitis C Persist After Achieving a Sustained Virologic Response. International Liver Transplant Society, Seoul, Korea. May 4-7, 2016. Poster Presentation.
580
Shike H, Kadry Z, Shah RA, Imamura Y, Greene W, Gaspari J, Riley T, Nathan H, Hasz R, Jain A. Quantitative Hepatitis C virus (HCV) RNA in plasma and kidney tissue in HCV antibody positive donors. American Transplant Congress, Boston, Massachusetts. June 11-15, 2016. Poster Presentation.
581
Jain A, Kadry Z. Measurement of Creatinine clearance in immediate post Kidney transplant (KTx) period with functioning allograft. 26 th Annual International Congress of The Transplant Society, Hong Kong. August 18-23, 2016. Poster Presentation.
582
Ye Tian, Liao Xiaojie Liao, Kadry Z, Shike H, Ghahramani N, Farooq U, Wassner S, Jain A. Long-term outcome post donor-specific antibody (DSA) mediated rejection in children and adults Kidney transplant recipient (KTx) treated with plasmapheresis, Immunoglobulin, and Rituximab. American Society of Transplant Surgeons Annual State of the Art Winter Symposium, Miami Beach, FL. January 26-29, 2017. Poster Presentation
583
Tian Y, Liao X, Kadry Z, Jain A. Incidence of deterioration of hepatic function despite sustained virological response (SVR) from direct acting anti-hepatitis C viral (HCV) therapy in post-liver transplant (LTx) recipients: possible etiological factors, management, and prevention. American Society of Transplant Surgeons Annual State of the Art Winter Symposium, Miami Beach, FL. January 26-29, 2017. Poster Presentation.
584
Jain A, Kadry Z. Early Metastatic Recurrence of Hepatocellular Carcinoma (HCC) in Post-Liver Transplant Recipient Treated with Direct Acting Antiviral Therapy, Case Reports: Is It Real or Incidental? at Joint International Congress of ILTS, ELITA & LICAGE May 24-27 Prague Czech Republic.
585
Jain A, Kadry Z. Biochemical Deterioration and Histological Changes Post-Liver Transplant (LTx) HCV-positive patients after Direct Acting Antiviral Therapy (DAA) with Sustained Virological Response (SVR); possible causes and management; at Joint International Congress of ILTS, ELITA & LICAGE May 24-27 Prague Czech Republic (P368).
586
Miller D, Kadry Z, Sharma R, Riely T, Krok K, Dohi T, Jain A. Does direct-acting anti-hepatitis C viral therapy increase the risk of recurrence of hepatocellular carcinoma post-liver transplantation? Poster Presentation. American Society of Transplant Surgeons 18 th Annual State of the Art Winter Symposium Miami Beach, FL. January 11-14,
587
A. Jain, T. Valania, T. Dohi, F. Butt. Z. Kadry Could IL-2 receptor blocker be used for prolonged maintenance, calcineurin-free immunosuppression in post-liver transplant recipients? ILTS Congress 2019, Toronto, Canada May 15-18, 2019.
588
A.B Jain, U Farooq, A. Brooks, T. Dohi, F. Butt. Z. Kadry. Need for a new formula to estimate creatinine clearance in the immediate post-kidney transplant period with functioning allograft. 2019 American Transplant Congress. Boston June 1-5 2019
589
Sandra Cantera, Eileen Swartz. A. Jain: Plasmapheresis Decreases Belatacept Exposure: Requires Consideration for Dose and Frequency Adjustments’. Dept. Surgery, Div. Abdominal International transplant nurses Society (ITNS) 2022
590
Eileen Swartz, BSN, RN, CCTC; Ashokkumar Jain MD Long-term Longitudinal Follow-up Using Steroid-free Maintenance Immunosuppression Using Alemtuzumab in, Pediatric Kidney Transplantation, Penn State Health Milton S. Hershey Medical Center, Hershey, PA International transplant nurses Society (ITNS) 2021
589
Deborah Daoud, Jay A. Patel, MD, Ashokkumar Jain. Is Standardized Incidence Ratio (SIR) of De-Novo Malignancies Post Kidney/Heart Transplant Higher than in Liver Transplant? Abstract ID Number: #306, The ASTS 22 nd Annual Winter Symposium Session Poster Session A, Poster Session A will be Thursday, January 13, 2022 from 5:30 - 7:00 PM E https://e.ctt.bz/e.asp?e=8ED98DAC-873B-40D8-A5FD-10DF30E5B858
590
Deborah Daoud, Jay A. Patel, MD, Ashokkumar Jain. Standardized Incidence Ratio (SIR) of De Novo Cancer Post Liver/Kidney Transplantation, Males versus Females: Does it Affect Survival Outcome? RE: Abstract # 105 The ASTS 22 nd Annual Winter; https://e.ctt.bz/e.asp?e=DBAE1371- C2E3-4C5C-9C2F-06CE0A6121E7
591
Deborah Daoud, Jay A. Patel, MD, Ashokkumar Jain Review Of Standardized Incidence Ratios (SIR) Of Non-Lymphoid De Novo Malignancies After Liver Transplantation: Structured Analysis Of Global Differences Abstract # 9, The ASTS 22 nd Annual Winter Symposium, Poster Session A Thursday, January 13, 2022 from 5:30 - 7:00 PM ET https://e.ctt.bz/e.asp?e=9C2E7EE0-C9B8-40F4- AC2C-2FC9913D4358
592
A Jain, Greene W. Hypothermic pulsatile flush of hepatitis C virus (HCV) RNA positive kidney reduces viral load Accepted oral presentation at ATC June 2022 Boston.
593
A. Jain and D. Haussner et. Al. Sarcopenia and Testosterone Deficiency with Chronic Liver Disease; Post-liver transplant Utility Of Short Term Testosterone Replacement Therapy. Poster presentation at ATC June 2022 Boston.
594